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A B S T R A C T
Background
Acute respiratory infections (ARIs) last for less than 30 days and are the most common acute diseases affecting people worldwide.
Exercise has been shown to improve health generally and may be effective in reducing the occurrence, severity and duration of acute
respiratory infections.
Objectives
To evaluate the effectiveness of exercise for altering the occurrence, severity or duration of acute respiratory infections.
Search methods
We searched CENTRAL (2014, Issue 6), MEDLINE (1948 to July week 1, 2014), EMBASE (2010 to July 2014), CINAHL (1981 to
July 2014), LILACS (1982 to July 2014), SPORTDiscus (1985 to July 2014), PEDro (searched on 11 July 2014), OTseeker (searched
on 11 July 2014), theWHO International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov (searched on 11 July 2014).
Selection criteria
Randomised controlled trials (RCTs) and quasi-RCTs of exercise for ARIs in the general population.
Data collection and analysis
Two review authors independently extracted data from the included trials using a standard form. We contacted trial authors to request
missing data. One review author entered data and a second review author checked this. There were sufficient differences in the
populations trialled and in the nature of the interventions to use the random-effects model (which makes fewer assumptions than the
fixed-effect model) in the analysis.
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Main results
We included 11 trials involving 904 adults, published between 1990 and 2014. Eight studies were conducted in the USA, and one
each in Canada, Spain and Turkey. Sample sizes ranged from 20 to 154 participants aged between 18 and 85 years old. The proportion
of female participants varied between 52% and 100%. The duration of follow-up in the studies varied from seven days to 12 months.
The exercise type most prescribed for the intervention was aerobic (walking in 70% of the studies, or bicycle riding or treadmill) at
least five times a week. Duration was 30 to 45 minutes at moderate intensity. Participants were supervised in 90% of the studies.
For four of the primary outcomes the results did not differ significantly and all were low-quality evidence (number of ARI episodes
per person per year, rate ratio 0.91 (95% confidence interval (CI) 0.59 to 1.42); proportion of participants who experienced at least
one ARI over the study period, risk ratio 0.76 (95% CI 0.57 to 1.01); severity of ARI symptoms, mean difference (MD) -110 (95%
CI -324 to 104); and number of symptom days in the follow-up period, MD -2.1 days (95% CI -4.4 to 0.3)). However, one primary
outcome, the number of symptom days per episode of illness, was reduced in those participants who exercised (MD -1.1 day, 95% CI
-1.7 to -0.5, moderate-quality evidence).
We found no significant differences for the secondary outcomes (laboratory parameters (blood lymphocytes, salivary secretory im-
munoglobulin and neutrophils); quality of life outcomes; cost-effectiveness and exercise-related injuries).
There was good adherence to the intervention with no difference between the exercise and non-exercise groups.
We rated the quality of evidence for the primary outcomes as low for most outcomes using the GRADE criteria: allocation concealment
was not reported and there was a lack of blinding; in addition, there was imprecision (the CI is very wide because of a small number
of participants) and inconsistency, which may be due to differences in study design.
Authors’ conclusions
We cannot determine whether exercise is effective at altering the occurrence, severity or duration of acute respiratory infections. One
analysis of four trials suggests that the number of days of illness per episode of infection might be reduced by exercise. The small size
of the studies, risk of bias and heterogeneous populations trialled all contribute to the uncertainty. Larger studies, with less risk of bias
from patient selection, blinding of outcomes assessors, reporting of all outcomes measured and with registration of study protocols, are
required to settle the question.
P L A I N L A N G U A G E S U M M A R Y
Is exercise effective for changing the occurrence, severity or duration of acute respiratory infections?
Background
Exercise has been shown to improve health generally. We undertook this review to test whether exercise is effective at changing the
occurrence, severity or duration of acute respiratory infections, i.e. colds and coughs that last less than a month.
Study characteristics
A search of the major databases to July 2014 found 11 trials involving 904 participants between the ages of 18 and 85 years old, which
tested the effect of exercise on acute respiratory infection symptoms. Exercise was supervised and prescribed at least five times a week,
with 30 to 45 minutes of moderate-intensity activities in most studies.
Key results
The number of acute respiratory infections per person per year and the severity of these symptoms were similar in the exercising and
non-exercising groups. Similarly, the number of people experiencing at least one acute respiratory infection and the number of symptom
days in the follow-up period were similar among people who did or did not exercise. One analysis of four trials suggested that the
number of days of illness per episode of infection might be reduced by exercise.
Quality of evidence
The quality of the trials was poor, which means that there might be benefit or even harm attributable to exercise.
Conclusion
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We need further studies with fewer potential biases to understand whether exercise is able to reduce the occurrence, severity or duration
of acute respiratory infections.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Exercise for acute respiratory infections
Patient or population: healthy people
Settings: any setting
Intervention: bicycle, treadmill or walk
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No exercise Exercise
Number of ARI episodes
per person per year
Self reported
Follow-up: adjusted for 1
year
Median risk in study population
2.5 2.3 (95% CI 1.5 to 3.6) Rate ratio 0.91 (0.59 to
1.42)
213
(2 studies)
⊕⊕©©
low1,3
Proportion of people who
experienced at least 1
ARI over the study period
Follow-up: 12 to 52
weeks
Median risk in study population
55 per 100 42 per 100 (95% CI 31
to 56)
RR 0.76
(0.57 to 1.01)
219
(3 studies)
⊕⊕©©
low 1,3
This outcome combines
a wide range of follow-up
periods
Global severity over 8
weeks
Self reported
mean 358 points mean 110 lower (324
lower to 104 higher)
98
(1 study)
⊕⊕©©
low 1,2
This scale is an area un-
der the curve (WURSS-24
score by days of illness)
Number of symptom
days over 12 weeks
Median of study population
mean 8.7 mean 2.1 lower (4.4
lower to 0.3 higher)
208
(3 studies)
⊕⊕©©
low 1,3
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Number of symptom
days per episode of ARI
(over 12 weeks)
Median of study population
mean 6.7 days mean 1.1 lower
(1.7 lower to 0.5 lower)
256
(4 studies)
⊕⊕⊕©
moderate 1
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RR: risk ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Limitations in the design and implementation. Risk of selection bias and lack of blinding; allocation concealment not reported in the
studies.
2Imprecision of results. The confidence interval is very wide because of a small number of participants.
3Inconsistency of results. Heterogeneity between studies may be due to differences in populations, intensity and duration of the
intervention and length of follow-up period.
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B A C K G R O U N D
Description of the condition
Acute respiratory infections (ARIs) are the most common acute
diseases affecting people worldwide (Bellos 2010; Del Mar 2000).
They are defined as infections of the respiratory tract that last for
less than30days (WHO 1990). ARIs have an estimatedworldwide
annual death rate of 4.25 million people and a total of one to
two years in every person’s life is spent suffering from ARIs (Del
Mar 2000; WHO 2002; WLF 2010). They are one of the most
common causes for consultation in primary care (Thomas 2000).
ARIs can be caused by viral or bacterial pathogens. Viral ARIs
alone cost the USAUSD 40 billion annually in direct and indirect
costs (Fendrick 2003). There are preventive strategies against ARIs
in the community, including stopping smoking, hand washing,
avoiding sick contacts, good nutrition and vaccines (Cohen 1993;
Jefferson 2011; Roth 2008).
Description of the intervention
Exercise has been shown to improve health generally. It may be
effective at reducing the occurrence, severity and duration of ARIs
(Barrett 2012; Chubak 2006; Nieman 2010; Obasi 2012). We
define exercise as “a planned and structured program of motor
actions to improve or maintain components of physical fitness”
(Carpersen 1985). The types of exercise prescribed can vary by
mode, dose, setting, the person who delivers the intervention and
any accompanying behavioural strategies (i.e. counselling, pam-
phlets) (Campbell 2007).
How the intervention might work
People who regularly exercise enjoy improvements in general
health and better maximal oxygen uptake (VO2 max), muscular
strength, flexibility and body composition (Warburton 2006). A
specific effect on ARIs could theoretically include: decreased age-
associated immunosenescence; improved innate immune func-
tion; mucosal immunity; decreased inflammatory cytokines and
stress resistance (Chubak 2006; Engels 2004; Manzaneque 2004;
Nieman 2010).
Why it is important to do this review
Exercise is a low-cost and readily available intervention that most
people could implement. We have identified no prior systematic
review that evaluates trial evidence about the effectiveness of exer-
cise for altering the occurrence, severity or duration of acute res-
piratory infections. Observational studies have shown an associa-
tion between exercise and decreased rates of ARIs (Chubak 2006;
Nieman 2010). However, this might be attributable to several bi-
ases.
O B J E C T I V E S
To evaluate the effectiveness of exercise for altering the occurrence,
severity or duration of acute respiratory infections.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs of exercise
versus no exercise for the occurrence, severity and duration of acute
respiratory infections in the general population. We also planned
to include trials that used a cross-over or cluster-RCT design.
Types of participants
Individuals of all ages including people with chronic respiratory
conditions. We considered the definition of ARIs used by the trial
authors.
Types of interventions
We included studies that used exercise in at least one group and
compared it to non-exercising or no intervention.We documented
all reported details of the intervention duration, frequency of ses-
sions and the season of the exercise programme. Comparisons in-
cluded were:
1. exercise versus sedentary lifestyle;
2. exercise versus usual care;
3. exercise versus non-exercising.
Types of outcome measures
Primary outcomes
1. Number of ARI episodes per person per year.
2. Proportion of participants who experienced at least one
ARI over the study period.
3. Severity of ARI symptoms.
4. Number of symptom days in the follow-up period (12
weeks).
5. Number of symptom days per episode of illness.
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Secondary outcomes
1. Laboratory-assessed immune parameters.
2. Quality of life.
3. Cost to the patient.
4. Exercise-related injuries.
5. Adherence to the group intervention.
Search methods for identification of studies
Electronic searches
We searched CENTRAL (2014, Issue 6), which contains the
Cochrane Acute Respiratory Infections Group’s Specialised Reg-
ister, MEDLINE (1948 to July week 1, 2014), EMBASE (1974
to July 2014), CINAHL (1981 to July 2014), LILACS (1982 to
July 2014), SPORTDiscus (1985 to July 2014), PEDro (11 July
2014) and OTseeker (11 July 2014).
We used the search strategy described in Appendix 1 to search
MEDLINEandCENTRAL.We combined theMEDLINEsearch
with the Cochrane Highly Sensitive Search Strategy for iden-
tifying randomised trials in MEDLINE (Lefebvre 2011). We
adapted the search strategy to search EMBASE (Appendix 2),
CINAHL (Appendix 3), LILACS (Appendix 4) and SPORTDis-
cus (Appendix 5). We did not use any language or publication
restrictions.
Searching other resources
We searched the World Health Organization (WHO) Interna-
tional Clinical Trials Registry Platform (ICTRP) and ClinicalTri-
als.gov for completed and ongoing studies (11 July 2014). We
checked the reference lists of all primary studies and review articles
for additional references. We emailed experts in the field about
unpublished data that might be included.
Data collection and analysis
Selection of studies
Two review authors (AJG, JK) independently assessed all stud-
ies resulting from the database searches by screening titles and
abstracts. We identified potentially eligible studies for full-text
reading. A third review author (TH) resolved any disagreements.
We described reasons for including and excluding trials (Higgins
2011a).
Data extraction and management
Two review authors (AJG, JK) independently extracted data from
the included studies using an online form developed for this pur-
pose. Two review authors (AJG, EB) entered the extracted data
into RevMan 2014.
Assessment of risk of bias in included studies
Two review authors (AJG, JK) independently assessed the risk of
bias for each included study using the ’Risk of bias’ tool pub-
lished in Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011b). Two review authors (CDM, EB) resolved any
disagreements by discussion. We assessed the risk of bias according
to the following domains.
1. Random sequence generation (selection bias).
2. Allocation concealment (selection bias).
3. Blinding of participants and personnel (performance bias).
4. Blinding of outcome assessment (detection bias).
5. Incomplete outcome data (attrition bias).
6. Selective reporting (reporting bias).
7. Other bias (other sources of bias related to particular trial
design (cross-over and cluster-randomised) or specific
circumstances.
We classified the risk of bias as: low risk, high risk or unclear risk
of bias (Higgins 2011b).
Measures of treatment effect
Types of measurements of treatment effect that we used included
the following.
1. Dichotomous data: we used risk ratio (RR) for the binary
outcomes: proportion of people who experienced at least one
ARI over the study period, exercise-related injuries and
adherence to the group intervention.
2. Continuous data: the measures were evaluated in numerical
quantity. We combined the results using the mean difference
(MD) for measures using the same scale for the outcomes:
severity of ARI; number of symptom days in the follow-up period
(12 weeks); number of symptom days per episode; laboratory
parameters - lymphocytes; quality of life; and financial cost to
the patient (USD). We also used standardised MD (SMD) where
different scales had been used to evaluate the same outcome for
laboratory parameters - IgA; laboratory parameters - neutrophils.
3. Rate: we used rate ratio to compare rates between groups
for the outcome number of ARI episodes per person/year.
Unit of analysis issues
We considered the individual the unit of analysis. No cross-over
or cluster-RCTs trials met our inclusion criteria.
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Dealing with missing data
We emailed (with one reminder email) the corresponding trial
authors to obtain missing data from published papers needed for
our analyses. We checked for consistency between the randomised
and analysed individuals to verify the intention-to-treat (ITT)
analysis in each outcome.
Assessment of heterogeneity
We assessed heterogeneity between studies using the I2 statistic
to describe the percentage of variability in effect. We considered
heterogeneity as substantial if the I2 statistic was above 50%.
Assessment of reporting biases
If we identified mismatches between study protocols and reports,
we contacted the trial authors to clarify the information. We had
planned to undertake a funnel plot if 10 or more trials were meta-
analysed but there were fewer than 10.
Data synthesis
We were able to perform meta-analyses with some trials that al-
lowed for the combination of data.We used the forest plot graphics
produced by RevMan 2014 to illustrate the meta-analyses. Where
a combination of data was not possible, we presented a description
of individual studies.
We had planned to use a fixed-effect model if heterogeneity was
acceptable (I2 statistic < 50%) but we decided that the nature of
the studies was so different (both the nature of the interventions
and the populations studied), that we needed to a use a random-
effects model instead.
For dichotomous data we were able to perform meta-analyses for
the outcomes: proportion of people who experienced at least one
ARI over the study period and adherence to the group intervention
using RR. We performed the meta-analyses using RR.
For continuous data we were able to perform meta-analyses for
the outcomes: number of symptom days in the follow-up period
(12 weeks); number of symptom days per episode; laboratory pa-
rameters - lymphocytes, IgA and neutrophils. We performed the
meta-analysis using MD and SMD.
For rate data we were able to perform a meta-analysis for the
outcome number of ARI episodes per person/year. We performed
the analysis using the log of the rate ratio and standard errors and
the generic inverse variance method.
Subgroup analysis and investigation of heterogeneity
We conducted the only possible subgroup analysis for the outcome
adherence to the group intervention. We conducted this analysis
to generate a new hypothesis regarding the effect of the length of
the intervention on adherence.
1. Length of intervention (short-term: less than six weeks,
medium-term: seven to 15 weeks, long-term: more than 16
weeks).
Sensitivity analysis
We pooled the included studies to verify whether the impact of
risk of bias affected the overall treatment effect of exercising. We
also explored which studies contributed to heterogeneity.
’Summary of findings’ table (SoF)
We developed a ’Summary of findings’ table using the methods
and recommendations described in section 8.5 and section 12 of
the Cochrane Handbook for Systematic Reviews of Interventions (
Higgins 2011b; Schünemann 2011a; Schünemann 2011b), and
using the GRADEpro software (GRADEpro 2008).
The following primary outcomes are presented in the ’Summary
of findings’ table: number of ARI episodes per person per year;
proportion of people who experienced at least one ARI over the
study period; severity of ARI; number of symptom days over 12
weeks; number of symptom days per episode (over 12 weeks). We
presented all outcomes in the text of the review.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
See Figure 1.
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Figure 1. Prisma flow diagram.
We identified 7186 references from the initial search by combining
all pre-specified databases, handsearching of reference lists, grey
literature and trial register search results. There were a total of 4853
references after duplicates were removed, of which we removed
4821 after title and abstract screening by two review authors. We
identified the remaining 32 references as potentially relevant and
retrieved full-text articles. From these 32 records, 18 did not meet
the inclusion criteria. Two review authors agreed on 14 research
papers from 11 trials that fulfilled the study inclusion criteria for
this review.
Included studies
See Characteristics of included studies and Table 1 and Table 2.
Eleven trials involving 904 adults, published between 1990 and
2014, met the inclusion criteria. All studies were published in
the English language. Eight studies were from the USA (Barrett
2012; Chubak 2006;Nieman 1990;Nieman 1993;Nieman 1997;
Sloan 2013;Weidner 1998;Weidner 2003), one was fromCanada
(Klentrou 2002), one was from Spain (Manzaneque 2004), and
one was from Turkey (Cilo lu 2005). Sample sizes ranged from
20 to 154 participants. Participants were aged between 18 and
85 years old. The proportion of female participants in each study
varied from 52% to 100%. The duration of the exercise interven-
tions varied from seven days to 12 months. The type of exercise
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usually prescribed was aerobic, of which bicycle riding, treadmill
or walking were prescribed in 73% of the studies. The exercise
sessions were performed five times a week (range three to seven
times/week) and all trials utilised 30 to 45 minutes of moderate-
intensity activities under supervision.
Excluded studies
We excluded 18 studies, with reasons provided in the
Characteristics of excluded studies table.
Risk of bias in included studies
The risk of bias for each included study is presented in Figure
2 and Figure 3. We found little evidence of selective reporting,
although only one study was registered. The main sources of risk
of bias were due to poor reporting.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Only one study clearly detailed the randomisation procedure
(Barrett 2012), while the other included studies did not provide
enough information to allow us to assess this adequately. One
study did not randomise adequately (participants were alternately
assigned to groups and therefore we judged this as a high risk
of bias) (Weidner 2003). We classified allocation concealment as
unclear in 90% of studies because of insufficient information in
the papers. We judged only one study as high risk of bias be-
cause the alternate method of randomisation (making this a quasi-
randomised controlled trial) allows prediction of assignment to
groups and is therefore easy to manipulate (Weidner 2003).
Blinding
The nature of the study interventions meant that blinding of par-
ticipants was not possible and we classified all studies as ’high’
risk of bias. Outcome assessor blinding was unclear because every
study provided insufficient information, except for Chubak 2006,
which collected outcome information by telephone interview and
Nieman 1990, who blinded participants to the study objectives.
Incomplete outcome data
We classified six studies as low risk of bias because they lost few
participants to follow-up, or reported missing data on colds or
other upper respiratory tract infection and adjusted data analysis.
Nieman 1990 and Nieman 1997 reported substantial loss to fol-
low-up and in the statistical analysis no intention-to-treat analysis
was used. We judged the other studies as having an unclear risk of
bias.
Selective reporting
OnlyBarrett 2012 registered the trial prior to conducting the study
(therefore was ’low’ risk of bias). We judged the other studies as
’unclear’ risk of bias because of incomplete reporting rather than
any detected differences between methods and results.
Other potential sources of bias
We judged all included studies to be free from other sources of
bias.
Effects of interventions
See: Summary of findings for the main comparison Exercise for
acute respiratory infections
Primary outcomes
1. Number of ARI episodes per person per year
For this outcome we found four relevant trials (n = 213) (Barrett
2012; Chubak 2006;Nieman 1990; Sloan 2013).However, we ex-
cluded Nieman 1990 and Sloan 2013 from the meta-analysis due
to lack of clarity in the data. Although there was a slightly lower
rate in the exercise group, there was no significant difference be-
tween exercise and non-exercise for ARI episodes (rate ratio 0.91;
95% CI 0.59 to 1.42, Analysis 1.1). This outcome had moderate
levels of heterogeneity (Chi2 test = 2.23; df = 1; P value = 0.14; I2
statistic = 55%). We downgraded the outcome from high to low
quality due to limitations in the design and implementation (risk
of selection bias and lack of blinding, allocation concealment not
reported in the studies) and inconsistency of results (heterogeneity
between studies may be due to differences in populations, inten-
sity and duration of the intervention and length of the follow-up
period).
2. Proportion of participants who experienced at least one
ARI over the study period
For this outcome we found three relevant trials (n = 219) (Barrett
2012; Chubak 2006; Nieman 1993). The difference between par-
ticipants in the exercise group (who had a lower proportion experi-
encing acute respiratory infection) and those in the non-exercising
group was not statistically significant (risk ratio (RR) 0.76; 95%
CI 0.57 to 1.01, Analysis 1.2). This outcome had low levels of
heterogeneity (Chi2 test = 2.49; df = 2; P value = 0.29; I2 statistic =
20%). We downgraded the outcome from high to low quality due
to limitations in the design and implementation (risk of selection
bias and lack of blinding, allocation concealment not reported in
the studies).
3. Severity of ARI symptoms
For this outcome we only found one relevant trial (n = 98) (Barrett
2012). There was no significant difference between participants
in the exercise group and those in the non-exercise group in the
totalWURSS-24 score over the duration of episodes of ARI (mean
difference (MD) -110.0; 95% CI -323.53 to 103.53, Analysis
1.3). We downgraded the outcome from high to low quality due
to limitations in the design and implementation (lack of blinding)
and imprecision of results (the confidence interval is very wide
because of the small number of participants).
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4. Number of symptom days in the follow-up period (12
weeks)
For this outcome we found three relevant trials (n = 208) (Barrett
2012; Klentrou 2002; Nieman 1997). Nieman 1997 had a fac-
torial design: we combined the data for exercise and exercise and
diet and compared this combination with the combination of diet
alone and control. The exercise group had a mean of two days
fewer symptom days, but there was no statistically significant dif-
ference between participants in the exercise group and those in
the non-exercise group (MD -2.06; CI -4.39 to 0.27, Analysis
1.4). This outcome had moderate levels of heterogeneity (Chi2
test = 3.12; df = 2; P value = 0.211; I2 statistic = 36%). We down-
graded the outcome from high to low quality due to limitations
in the design and implementation (risk of selection bias and lack
of blinding, allocation concealment not reported in the studies)
and inconsistency of results (heterogeneity between studies may
be due to differences in populations, intensity and duration of the
intervention, and length of the follow-up period).
5. Number of symptom days per episode of illness
For this outcome we found four relevant trials (n = 256) (Barrett
2012; Cilo lu 2005; Nieman 1990; Sloan 2013). There was a sta-
tistically significant difference between participants in the exercise
group and those in the control group in the number of days per
episode of ARI, with the exercise group having approximately one
day less with symptoms in each episode (MD -1.13 days; 95%
CI -1.71 to -0.54, Analysis 1.5). This outcome had low levels of
heterogeneity (Chi2 test = 3.3; df = 3; P value = 0.35; I2 statis-
tic = 9%). We downgraded the outcome from high to moderate
quality due to limitations in the design and implementation (risk
of selection bias and lack of blinding, allocation concealment not
reported in the studies).
Secondary outcomes
1.1. Laboratory-assessed immune parameters - lymphocytes
For this outcome we found three relevant trials (n = 157) (Nieman
1990; Nieman 1993; Nieman 1997). There was a very small mean
increase in the exercise group compared with the non-exercise
group, but this difference was not statistically significant (MD
0.11; 95% CI -0.10 to 0.31, Analysis 1.6). This outcome had
low levels of heterogeneity (Chi2 statistic = 2.21; df = 2; P value
= 0.33; I2 statistic = 10%). We downgraded the outcome from
high to moderate quality due to limitations in the design and
implementation (lack of blinding).
1.2 Laboratory-assessed immune parameters - IgA
For this outcome we found four relevant trials (n = 166) (Cilo lu
2005; Klentrou 2002;Manzaneque 2004; Sloan 2013). There was
no significant difference between participants in the exercise group
and the non-exercise group (standardised MD (SMD) 0.07; 95%
CI -0.37 to 0.52, Analysis 1.7). This outcome had moderate levels
of heterogeneity (Chi2 test = 5.14; df = 3; P value = 0.16; I2
statistic = 42%). We downgraded the outcome from high to low
quality due to limitations in the design and implementation (lack
of blinding).
1.3 Laboratory-assessed immune parameters - neutrophils
For this outcome we found three relevant trials (n = 214) (Barrett
2012; Manzaneque 2004; Nieman 1997). There was no signif-
icant difference between participants in the exercise group and
those in the non-exercise group (SMD -0.11; 95% CI -0.44 to
0.22, Analysis 1.8). This outcome had low levels of heterogeneity
(Chi2 test = 2.44; df = 2; P value = 0.3; I2 statistic = 27%). We
downgraded the outcome from high to low quality due to limita-
tions in the design and implementation (lack of blinding).
2. Quality of life
Only one study analysed quality of life (n =98), whichwas reported
in two separate domains (physical and mental health) (Barrett
2012). This study included 47 participants in the exercise group
and 51 participants in the control group. The physical health do-
main (MD 1.40; 95% CI -2.32 to 5.12) and the mental health
domain (MD 3.40; 95% CI -0.60 to 7.40) were not statistically
significant (Analysis 1.9).We downgraded the outcome from high
to low quality due to limitations in the design and implementa-
tion (lack of blinding) and imprecision of results (the confidence
interval is very wide because of the small number of participants).
3. Cost to the patient (USD)
For this outcome we only found one relevant trial (n = 8) (Barrett
2012). There was no significant difference between participants
in the exercise group and those in the non-exercise group (MD -
78.00; CI -219.60 to 63.60, Analysis 1.10). We downgraded the
outcome from high to low quality due to limitations in the design
and implementation (lack of blinding) and imprecision of results
(the confidence interval is very wide because of the small number
of participants).
4. Exercise-related injuries
For this outcomewe only foundone relevant trial (n =30) (Nieman
1993). There was no significant difference between participants in
the exercise group and those in the non-exercise group (RR 5.67;
CI 0.29 to 108.91, Analysis 1.11). We downgraded the outcome
from high to low quality due to limitations in the design and
implementation (lack of blinding) and imprecision of results (the
confidence interval is very wide because of the small number of
participants).
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5. Adherence to the group intervention
For this outcome we found eight relevant trials (n = 499) (Barrett
2012; Chubak 2006; Cilo lu 2005; Klentrou 2002; Manzaneque
2004; Nieman 1990; Nieman 1993; Sloan 2013). There was no
significant difference between the participants in the exercise group
and those in the non-exercise group (RR 0.98; CI 0.95 to 1.02,
Analysis 1.12). This outcome had low levels of heterogeneity (Chi
2 test = 6.38; df = 7; P value = 0.50; I2 statistic = 0%). We down-
graded the outcome from high to moderate quality due to limita-
tions in the design and implementation (lack of blinding).
Sensitivity analysis
We found no important levels of heterogeneity for any of the out-
comes analysed. Thus, there was no need for further exploration.
D I S C U S S I O N
Summary of main results
This review aimed to determine the effectiveness of exercise in
altering the occurrence, severity or duration of acute respiratory
infections (ARIs). Analysis of the following primary outcomes
showed no significant differences between people who exercised
and those who did not: number of ARI episodes per person per
year; proportion of participants who experienced at least one ARI
over the study period; severity of ARI symptoms; and number of
symptom days in the follow-up period. However, the primary out-
come of number of symptom days per episode was significantly
lower in people who exercised. In a subgroup analysis of ’adherence
to the intervention group’, which we used to consider whether
the effect of the length of the intervention affected adherence, we
found no significant differences.
Secondary outcomes (laboratory parameters such as lymphocytes,
IgA and neutrophils) were similar in both groups. Similarly, for
quality of life outcomes we found no significant difference with
exercise for physical and mental health quality of life. The one
study that presented data on cost-effectiveness foundno significant
benefits of exercise. The one study that provided data on exercise-
related injuries showed no significant difference between people
who exercised compared to those who did not. We observed no
significant differences in adherence between the exercise or control
group.
Overall completeness and applicability of
evidence
Eleven trials randomised 904 participants who commenced the
intervention and 35 participants were lost to follow-up. Data were
limited in terms of the number of outcomes. Most studies did not
provide enough information to enable a secure assessment of risk
of bias. We have also highlighted the poor reporting of the studies
and most trial authors did not choose patient-centred outcomes.
Quality of the evidence
Only one study clearly described the randomisation process
(Barrett 2012).
The characteristics of exercise interventions mean that it is not
possible to blind participants. While outcome assessors could be
blinded, only one study provided enough information to confirm
this was done.
Attrition bias appeared to be a high risk among some studies.
Intention-to-treat analysis, or another statistical strategy, could
have been used to adjust for loss to follow-up.
The GRADE quality of evidence for the primary outcomes ranks
from high to low across different outcomes, because of the lack
of blinding, risk of selection bias (allocation concealment not re-
ported in the studies) and imprecision (the confidence interval was
very wide because of the small number of participants).
Several of the studies appear to have focused on pathophysiological
processes rather than pragmatic outcomes of interest to patients.
This is not a problem of selective reporting so much as a different
research objective in these studies compared to the objectives of
our review.
Potential biases in the review process
Themain limitation of this review is the lack of information to en-
able us to appropriately judge the risk of bias, the clinical variabil-
ity and the lack of consistent criteria for ARI classification. Most
trials were not registered, presenting another potential source of
bias, although we found no ongoing studies in clinical trials reg-
istries.
Agreements and disagreements with other
studies or reviews
We found one narrative systematic review of physical activity and
the risk of ARI among athletes. It reported on 30 studies published
until 2009 (with 8575 athletes and 1798 non-athletes). The au-
thors highlighted the heterogeneity problem of exercise intensity,
duration and the widely variety of participants included in the
primary studies, as well as the different types of study designs. The
authors were careful to identify the same problems with risk of bias
that we did. We are in agreement with the need for better method-
ological rigour (Moreira 2009). The review also speculates that
there is a “J”-shaped curve that describes the relationship between
physical activity and risk of ARI (that both low and high levels of
physical activity increase the risk of ARI, while moderate levels of
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physical activity reduce the risk) (Moreira 2009). Our systematic
review could not test this hypothesis because our included studies
tested moderate exercise.
Another systematic review using Cochrane methods has evalu-
ated exercise for preventing the common cold and included four
randomised controlled trials with a total of 281 participants (Lee
2014). It reports that prevention of the common cold and mean
illness days were significantly lower in the exercise groups. One
difference between that systematic review and this one appears to
be the inclusion criteria: our search was broader and more com-
prehensive (including more studies and more outcomes).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We cannot determine whether exercise is effective at altering the
occurrence, severity or duration of acute respiratory infections
(ARIs). One analysis of four trials suggests that the number of days
of illness per episode of infection might be reduced by exercise.
However, this may not be enough to change clinical decision-
making (advocating exercise to prevent ARIs) because of the low
quality of evidence and the risk of bias in most studies.
Implications for research
Despite epidemiological data appearing to support a reduced oc-
currence of ARIs with increased physical activity, more and bet-
ter randomised controlled trials (RCTs) are needed to answer the
question about the effects of exercise on the occurrence, severity
and duration of ARIs. Greater methodological rigour is needed
for future research (patient selection, blinding of outcome asses-
sors, reporting of all outcomes analysed and registration of study
protocols).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Barrett 2012
Methods STUDY DESIGN: randomised controlled trial
LOCATION, NUMBER OF CENTRES: outpatient clinic adults from University of
Wisconsin Department of Family Medicine
STUDY PERIOD: 8-week training in mindfulness meditation, matched; 8-week train-
ing in moderate-intensity sustained exercise, or observational control. For the analysis
we used the exercise group and control group
METHODSOFANALYSIS: “ARI illness episode, severity was assessed once daily using
a 24-item version of theWisconsin Upper Respiratory, Symptom Survey (WURSS). The
WURSS-24 adds items assessing headache, body aches and fever to the well-validated
WURSS-21. With each ARI illness episode, a nasal wash was collected within 3 days
of symptom onset and analysed for interleukin-8 (IL-8), neutrophil count and viral
nucleic acid. Elevatedneutrophil count and IL-8 levels are indicators of inflammation and
correlate with symptom severity and viral shedding. Multiplex polymerase chain reaction
(PCR)methods developed and validated at UWwere used to identify respiratory viruses.
Several validated self report questionnaires were used to explore potential explanatory
pathways linking behavioural interventions to ARI outcomes SF-12; PSS-10; Positive
and Negative Affect Schedule (PANAS); State Trait Anxiety Inventory (STAI); Life
Orientation Test (LOT); Positive Relationships with Others (PR) scale. The Pittsburgh
SleepQuality Index (PSQI); The International Physical Activity Questionnaire (IPAQ);
Mindful Attention Awareness Scale (MAAS). Health Care Utilization and Days of Work
or School Missed”
STATISTICAL ANALYSIS: “the sample size of 150 was based on power estimates con-
trasting (1) meditation versus control and (2) exercise versus control. To control for
multiple testing, a P value ≤ 0.025 cutoff for null hypothesis rejection was chosen. 1-
sided testing was justified by previously published research, all in the direction of positive
results”
“Unadjusted between-group contrasts were calculated using 1-sided t tests for continuous
variables and proportional difference testing for binomials. Most participants did not
experience ARI illness, therefore zero inflated regression models were used to control
for potential confounders. These models take into account both logistic (incidence) and
linear (days of illness or global severity) data. Covariates used in these models were age,
sex, education, smoking status, body mass index, baseline physical and mental health
(SF-12) and cohort. Global severity was skewed, therefore Box-Cox transformation was
used for this outcome in these models. To explore potential causal pathways, we assessed
the relationship of secondary outcomes measured just after interventions to the main
outcomes”
Participants RECRUITMENTMEANS: community-targeted recruitment methods included adver-
tising in local media
TARGET PARTICIPANTS: adults aged 50 years or older
N RANDOMISED: 154 adults randomised
N COMPLETED: 149 adults completed; 47 (exercise); 51 (meditation); 51 (control)
GENDER
M = 27; exercise 8, meditation 9, control 10
F = 122; exercise 39, meditation 42, control 41
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AGE: exercise (59.0 ± 6.6), meditation (60.0 ± 6.5), control (58.8 ± 6.8)
BASELINE DETAILS: age, gender, smoking, race, BMI, education, income and every
questionnaire applied
Interventions SETTINGOF INTERVENTION: interventionswere conducted atUWResearch Park,
a multipurpose outpatient clinic with exercise facilities and space suitable for meditation
training
DESCRIPTION OF INTERVENTION: weekly group sessions were divided into di-
dactic instruction (cognitive, logistic and behavioural) and practice (moderately inten-
sive exercise using stationary bicycles, treadmills and other equipment). For most par-
ticipants, home exercise consisted of brisk walking or jogging
Mindfulness meditation: the standardised 8-week MBSR course includes weekly 2½-
hour group sessions and 45 minutes of daily at-home practice
Exercise: (8 weeks), contact time (weekly 2½ hour group sessions), home practice (45
minutes per day) and location
DELIVERED BY: exercise was applied by 3 qualified exercise instructors in clinical
exercise physiology. Meditation was applied by instructors with advanced degrees and
all were trained in Massachusetts by the Kabat-Zinn group
INTERVENTION PERIOD: 8 weeks
FOLLOW-UP PERIOD: 9 months
CO-INTERVENTIONS: didactic instruction (cognitive, logistic and behavioural)
Outcomes 1. Physical health, mental health (SF-12)
2. Negative emotion (PANAS); positive emotion (PANAS); optimism (LOT); social
support (Ryff PR); perceived stress (PSS-10); anxiety (current state) (STAI); sleep quality
(PSQI); mindfulness (MAAS)
3. Exercise, MET min/wk (IPAQ)
4. ARI illness burden: severity and duration (no. days), cold severity, symptoms, based
on each ARI illness episode, global severity score (area under the curve, AUC) for all
ARI illness days; symptom severity and impact on function and quality of life
Data collected (in 2 cohorts) over 7 or 9 months, but reported at 3 months
Notes STUDY FUNDING: “this study was supported by a grant from the National Insti-
tutes of Health (NIH), National Center for Complementary and Alternative Medicine
(1R01AT004313); and by a grant UL1RR025011 from the Clinical and Translational
Science Award (CTSA) Program of the National Center for Research Resources, Na-
tional Institutes of Health. Aleksandra Zgierska was supported by grant K23 AA017508
from National Institute on Alcohol Abuse and Alcoholism at NIH”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “[ ] software [ ] ... was used to generate 165
unique identification numbers in balanced
blocks of 3.”
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Allocation concealment (selection bias) Unclear risk “Codes were concealed in consecutively
numbered sealed envelopes, which were
opened after consent to indicate allocation.
” No mention of envelopes being opaque
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome measurement is by participant
self report, therefore cannot be blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Main outcomes only have data missing for
2 people
Selective reporting (reporting bias) Low risk The study protocol is available and the pre-
specified outcomes were published
Other bias Low risk The study seems to be free from other
sources of bias
Chubak 2006
Methods STUDY DESIGN: randomised controlled trial
LOCATION, NUMBER OF CENTRES: Fred Hutchinson Cancer Research Center
and the University of Washington
STUDY PERIOD: 12 months
METHODS OF ANALYSIS: “at baseline and 3, 6, 9 and 12 months, participants com-
pleted self administered questionnaires, modified from established, validated instruments
on the number of episodes of allergies, upper respiratory tract infections (colds and flu)
and other infections over the past 3 months”
STATISTICAL ANALYSIS: “Poisson regression allowed for use of data from all avail-
able time points without eliminating individuals with some missing data. We assumed
an unstructured working correlation matrix, computed robust standard errors and per-
formed an intention-to-treat analysis, with P value < 0.05 being considered statistically
significant. Results were identical or stronger when restricted to women who had assess-
ments at all 4 time points. We also evaluated whether the exercise effect differed by age
(< 60 versus ≥ 60 years) or regular multivitamin use, assessed by abstraction of vitamin
bottles brought into the clinic at baseline (see Shade et al for details). All analyses were
performed using SAS 8.0 (SAS Institute, Cary, NC) and Stata 8 (StataCorp, College
Station, Tex) statistical software. All P values are 2-sided”
Participants RECRUITMENT MEANS: mass mailings and media placements
TARGET PARTICIPANTS: post-menopausal women, overweight/obese, non-smok-
ing, sedentary
N RANDOMISED: 115 adult post-menopausal women
N COMPLETED: 115 post-menopausal women; 53 (exercise) and 62 (control)
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GENDER
F = 115; exercise 53, control 62
AGE: exercise 60.5 (7), control 60.9 (6.8)
Inclusion criteria: “post-menopausal; age, 50 to 75 years; in good health; non-smoking;
sedentary (< 60 minutes/week of moderate and vigorous-intensity recreational activity
and maximal oxygen consumption < 25.0 mL/kg per minute during a VO2 test); not
taking hormone replacement therapy in the past 6months; alcohol consumption of fewer
than 2 drinks per day; body mass index (BMI) between 25 and 40 or BMI 24.0 to 24.9 if
body fat > 33%; no history of invasive cancer, diabetes, cardiovascular disease, asthma; no
current serious allergies; no regular (≥ 2 times/week) use of aspirin or other nonsteroidal
anti-inflammatory medications; not using corticosteroids or other medications known to
affect immune function. Women were ineligible if they were volunteering for the study
to lose weight, had a history of surgery for weight loss, or were currently attempting, or
planning to attempt, weight loss by taking diet pills or entering a structured weight loss
programme. Participants had been weight stable for at least 3 months”
BASELINEDETAILS: demographic information, medical history, health habits, repro-
ductive history, physical activity, diet and anthropometric variables
Interventions SETTING OF INTERVENTION: Fred Hutchinson Cancer Research Center and the
University of Washington
DESCRIPTIONOF INTERVENTION: “the exercise intervention consisted of at least
45 minutes of moderate-intensity exercise 5 days/week for 12 months. During months
1 through 3, participants were required to attend 3 sessions per week at 1 of the study
facilities and to exercise 2 days/week at home. For months 4 through 12, participants
were required to attend at least 1 session per week at the facility and to exercise the
remaining days on their own for a total of 5 days/week (participants were allowed to
exercise additional days at the facility if they chose). The training programme began with
a target of 40%ofmaximal heart rate for 16minutes per session and gradually increased to
60% to 75% ofmaximal heart rate for 45minutes per session by week 8, at which point it
was maintained for the duration of the study. Participants wore heart rate monitors (Polar
Electro Inc, Woodbury, NY) during their exercise sessions. Facility sessions consisted of
treadmill walking and stationary bicycling. Strength training, consisting of 2 sets of 10
repetitions of leg extension, leg curls, leg press, chest press and seated dumbbell row, was
recommended but not required to decrease risk of injury and maintain joint stability.
A variety of home exercises were suggested and encouraged, including walking, aerobics
and bicycling. Participants were encouraged to wear their heart rate monitors when
exercising at home.Women randomly assigned to the control group attended weekly 45-
minute stretching sessions for 1 year and were asked not to change other exercise habits
during the study. Exercise and control participants were asked to maintain their usual
diet”
DELIVERED BY: not stated
FOLLOW-UP PERIOD:12 months
CO-INTERVENTIONS: none
Outcomes Multivitamin, number of colds before baseline, number of upper respiratory tract infec-
tions, allergy episodes, influenza immunisation
PRE-SPECIFIED: 3 months before baseline
FOLLOW-UP PERIOD: 12 months
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Notes STUDY FUNDING: “National Cancer Institute (NCI) (R01 CA 69334). Ms. Chubak
was supported by grant T32 CA09168 from the NCI. The contents of this publication
are solely the responsibility of the authors and do not necessarily represent the official
views of the NCI or National Institutes of Health. Dr. Wener was supported in part by
the University of Washington Clinical Nutrition Research Grant (DK35816)”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Participantswere enrolled in a randomised
trial...” Not enough information provided
to judge
Allocation concealment (selection bias) Unclear risk No information regarding allocation con-
cealment was provided in the text
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcomes are by participant self report. In-
formation was obtained by telephone for
outcomes ARI episodes and URI
Incomplete outcome data (attrition bias)
All outcomes
Low risk They reported missing data on colds or
other upper respiratory tract infection
episodes at 6 and 9 months. It was less than
10%
Selective reporting (reporting bias) Low risk The study protocol is not available, al-
though all relevant outcomes we wanted
were reported
Other bias Low risk The study seems to be free from other
sources of bias
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Cilo lu 2005
Methods STUDY DESIGN: parallel-group randomised controlled trial
LOCATION, NUMBER OF CENTRES: Genlab Medical Diagnostics and Research
Laboratory
STUDY PERIOD: September to November
METHODS OF ANALYSIS: “the participants had anthropometrical measurements
in the fasting state. Body weight and height were measured on standard scale with an
attached ruler wearing light clothes and no shoes. Body mass index (BMI) was calculated
as weight in kilograms (kg) divided by the square of the height in metres (m). Waist
circumference was measured using a flexible measuring tape at the umbilicus level with
the participants standing straight, arms at their sides and feet together. Body fat mass and
fat free mass were determined by bioelectric impedance. During the supervised sessions,
participants were noted for and asked about upper respiratory infection symptoms of
runny stuffy nose, sore throat, coughing, sneezing coloured discharge and fever. Those
who were in the non-exercise group were phoned weekly for the same data collection.
Number of URTI episodes and the number of URTI days per episode were recorded for
each participant. An episode of URTI was defined as having the symptoms for more than
2 days and separated by at least 5 days from the previous episode. The saliva samples
were collected prior to starting the study and at the end of the 12 weeks each time after
the mouth had been rinsed thoroughly with distilled water. The saliva samples were
frozen at -20°C and stored until the end of the study period. Salivary IgA concentrations
were measured by enzyme linked immunosorbent assay (ELISA) method (Immulon II;
Dynex Technologies, Chantilly, Virginia, USA)”
STATISTICAL ANALYSIS: not stated
Participants RECRUITMENT MEANS: volunteers from the routine check up from the laboratory
TARGET PARTICIPANTS: post-menopausal women
N SCREENED: 90 post-menopausal women
N COMPLETED: 90 post-menopausal women
GENDER
F = 90; indoor exercise 30, outdoor exercise 30 and control 30
AGE: indoor exercise 55.0 ± 3.5, outdoor exercise 54.6 ± 2.1 and control 30 54.9 ± 3.8
EXCLUSION CRITERIA: “excluded for chronic disease, any medications including
vitamins, having received the flu shot and having smoked cigarettes within the last 2
years”
BASELINE DETAILS: age, weight, BMI, waist circumference, fat mass, fat free mass,
number of URTI episodes, number of URTI days per episode
Interventions SETTING OF INTERVENTION: Genlab Medical Diagnostics and Research Labora-
tory
DESCRIPTIONOF INTERVENTION: “both the indoor and outdoor exercise groups
underwent supervised exercise sessions 5 days a week for 30 minutes each time walking
on a treadmill or an outdoor tract respectively at 60% of their maximal heart rate as
determined by the simple formula of Maximal Heart Rate = 220 - age. Heart rate
measurements were done with a Polar Heart Rate Monitor”
DELIVERED BY: supervised sessions
FOLLOW-UP PERIOD: 12 weeks
CO-INTERVENTIONS: none
Outcomes Salivary IgA levels and the incidence of upper respiratory tract infections
FOLLOW-UP PERIOD: 12 weeks
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Notes STUDY FUNDING: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The authors did not explain how the ran-
dom sequence was generated “They were
divided into three groups ... with each
group having similar characteristics and
randomly assigned.”
Allocation concealment (selection bias) Unclear risk No information regarding allocation con-
cealment was provided in the text
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was no loss of data in the outcomes
analysed
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
Other bias Low risk The study seems to be free from other
sources of bias
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Methods STUDY DESIGN: parallel-group randomised controlled trial
LOCATION, NUMBER OF CENTRES: Brock University
STUDY PERIOD: February to May 2000
METHODS OF ANALYSIS: “to monitor the effectiveness of the exercise programme,
both groups were administered a continuous incremental exercise test on an electrically
braked cycle ergometer (Ergociser EC-1600, Cateyer Co. Ltd., Japan) for the determi-
nation of maximal aerobic power (VO2 max) at 3 separate times during the course of
the study: T1 - at the onset of the study (before any activity by the exercise group began)
, T2 - at the mid-point of training (6 weeks) and T3 - at the conclusion of training
(12 weeks). A volume of 1 ml of unstimulated whole mixed saliva was collected from
each participant at T1 and T3 using cylinder-shaped swabs placed in the mouth for 1
minute. Each participant was provided with a Health and Sickness Logbook to record
symptoms, as exhibited, daily”
“Participants were asked not to take any over-the-counter or prescription medication
that might mask their symptoms since the daily sickness log was based on symptoms
that the participant experienced or felt”
STATISTICAL ANALYSIS: “all statistical analyses were performed using SPSS (SPSS
Inc., Chicago Ill.). Comparison of inter-group differences was done using an ANOVA.
Changes in maximal [IgAs], [Albs] and [IgAs]:[Albs] with training were analysed using
a repeated measurements ANOVA. The accepted level of significance was set at P value
< 0.05. The experimental power was more than 99%. Pearson correlation analysis was
used to examine the strength of the relationship which existed between URTI and the
salivary variables”
Participants RECRUITMENT MEANS: not stated
TARGET PARTICIPANTS: healthy men and women
N SCREENED: 20 healthy men and women
N COMPLETED: 19 completed; 9 (exercise) and 10 (control)
GENDER: not informed
AGE: 25 to 50 years
INCLUSION CRITERIA: “adult men or women (aged 25 to 50 years) having a seden-
tary lifestyle, non-smokers, free of asthma, no recent influenza immunisation, free from
URTI at entry to the study and the women not being pregnant or planning on becom-
ing so. Furthermore, the majority of participants were only indirectly exposed to young
children and they all resided in the same area”
BASELINE DETAILS: age, VO2 max, IgA
Interventions SETTING OF INTERVENTION: Exercise Assessment and Research Centre
DESCRIPTION OF INTERVENTION: “the exercise programme consisted of 3 ex-
ercise sessions a week. Each exercise session was 45 minutes long. During the exercise
period, the participants performed a 30-minute aerobic protocol at 75% of heart rate
reserve using stationary bicycles, treadmills, stair climbers or combined/cross-training
using more than 1 device. At the end of the aerobic activities, participants spent an
additional 15 minutes doing stretching exercises involving the lower body, trunk and
arms. More specifically, each participant performed approximately 10 muscle stretches
including: quadriceps, calves, gluteal, lower back, triceps, biceps, shoulder, trapezius and
pectoralis. During the aerobic protocol, each participant’s heart rate was recorded at
3 different points: prior to starting exercise, mid-point of exercise and completion of
exercise (before cool-down) using a Polar heart rate monitor. All exercise sessions were
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conducted in a group format in the Exercise Assessment and Research Center to ensure
that participants exercised at the prescribed duration and intensity”
DELIVERED BY: not stated
FOLLOW-UP PERIOD: 12 weeks
CO-INTERVENTIONS: none
Outcomes Influenza symptoms, cold symptoms, total sickness days, VO2 max, symptoms recorded;
A concentration ([IgAs]), salivary albumin concentration ([Albs]) and [IgAs]:[Albs]
FOLLOW-UP PERIOD: 12 weeks
Notes STUDY FUNDING: Faculty of Health Sciences, Brock University
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The authors did not explain how the ran-
dom sequence was generated
Allocation concealment (selection bias) Unclear risk “After signing the informed consent, par-
ticipants were randomly assigned to either
the control group or the exercise group.”
Not enough information provided to judge
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk One participant (out of a total of 9) from
the exercise group was not included, with-
out reasons given
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
Other bias Low risk The study seems to be free from other
sources of bias
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Manzaneque 2004
Methods STUDY DESIGN: parallel group randomised controlled trial
LOCATION, NUMBER OF CENTRES: psychology students at the University of
Malaga
STUDY PERIOD: 1-month training period; Monday to Friday for 30 minutes
METHODS OF ANALYSIS: “the day before the study commenced, blood samples
were taken from all participants, in both the control and experimental group, at 9:30
in the morning and again 1 month later, at the end of the study, when qigong training
was concluded for the experimental participants. The immunological parameters inves-
tigated included the number of leukocytes (total leukocytes, monocytes, neutrophils,
eosinophils, basophils, lymphocytes, T lymphocytes and T helper lymphocytes), the
percentages of leukocytes (monocytes, neutrophils, eosinophils, basophils, lymphocytes
and T helper lymphocytes), as well as the concentrations of immunoglobulins (IgA, IgG
and IgM) and complement (C3 and C4). Total blood count - Pentra 120 ABX analyser.
Serum immunoglobulins and complement Immage, Immunochemistry System (Beck-
man Coulter)”
STATISTICAL ANALYSIS: “a between-group analysis of covariance (ANCOVA) was
performed on several dependent variables: the numbers of total leukocytes, monocytes,
neutrophils, eosinophils, basophils, lymphocytes, T lymphocytes and T helper lympho-
cytes; the percentages of lymphocytes, T helper lymphocytes, monocytes, neutrophils,
eosinophils and basophils; as well as the concentrations of IgG, IgA, IgM and the com-
plements C3 and C4. The qigong training was considered as an independent variable
with 2 levels (absence or control group and presence or experimental group) and the
respective pretest scores of each dependent variable as covariants. Thus, the differences
between groups were estimated with the differences in pretest scores removed. A P value
< 0.05 was considered to be significant, while P value < 0.1 was considered a trend
towards significance. Lymphocytes subsets: FACScan (Becton Dickinson)”
Participants RECRUITMENT MEANS: psychology students volunteers
TARGET PARTICIPANTS: adults
N SCREENED: 29 adults
N RANDOMISED: 29 adults randomised
N COMPLETED: 26 adults completed; 13 (qigong) and 13 (control)
GENDER: M = 12; F = 14
AGE: 18 to 21 years old
BASELINE DETAILS: age, gender
Interventions SETTING OF INTERVENTION: in a room adjoining the laboratory where the prac-
tice sessions were conducted
DESCRIPTION OF INTERVENTION: “the form of qigong taught is known as the
”eight pieces of brocade“ (Ba Duan Jin in Chinese pinyin transliteration). It is a simple
qigong method that contains 8 distinct movements and integrates them with breath-
ing and a relaxed state of the mind. The whole physical sequence contains 8 discrete
movements each, making a total of 64 physical movements to complete the entire set.
Throughout the practice, natural, relaxed and rhythmic breathing is required. This
method of qigong reportedly dates back hundreds of years and a number of physical
and psychological benefits ts has traditionally been attributed to it. More recently, 2
reports published in important international journals focused on this qigong style and its
health-promoting features. 30 minutes per session, 5 days per week for the month-long
intervention with instructor. Encouraged to do extra on weekends. No data reported on
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this extra practice”
DELIVERED BY: qualified qigong instructor of this discipline
INTERVENTION PERIOD: 1 month
FOLLOW-UP PERIOD: 1 month
CO-INTERVENTIONS: the medication was kept constant during the study period
Outcomes Leucocytes (× 103 cells/µl and %); monocytes (× 103 cells/µl and %); neutrophils (×
103 cells/µl and %); eosinophils (× 103 cells/µl and %); basophils (× 103 cells/µl and
%); lymphocytes (× 103 cells/µl and %); T lymphocytes (cells/µl and %); T helper
lymphocytes (cells/µl and %); IgA (mg/dl); IgG (mg/dl); IgM (mg/dl); C3 (mg/dl); C4
(mg/dl)
FOLLOW-UP PERIOD: blood sample at 9:30 in the morning the day before and again
1 month later, at the end of the study
Notes STUDY FUNDING: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The authors did not explain how the ran-
dom sequence was generated
Allocation concealment (selection bias) Unclear risk “16 subjects were randomly allocated to the
experimental group and 13 to the control
group, balancing the number of males and
females in each case”. Not enough infor-
mation provided to judge
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “One experimental subject (male) decided
to abandon the experiment without reasons
given within the first few days of onset and
a further two (one male and one female)
were excluded from the sample for non-
attendance at the qigong sessions on more
than two occasions”
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
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Other bias Low risk The study seems to be free from other
sources of bias
Nieman 1990
Methods STUDY DESIGN: parallel-group randomised controlled trial
LOCATION, NUMBER OF CENTRES: Loma Linda University
STUDY PERIOD: last weekend of January to mid to May 1989
METHODS OF ANALYSIS: “all participants reported to the Loma Linda University
Human performance Lab for testing at 0700 hours following 12 hours of fasting. Af-
ter resting for at least 5 minutes, blood samples were collected. Participants returned
throughout the day for assessment of the following: height and weight, body composi-
tion (hydrostatic weighing and 7-site skinfold tests), resting 12-lead EKG and 12-lead
EKG graded exercise testing with metabolic measurements. If a participant exhibited
overt symptoms of URI, the appointment was rescheduled. Maximal graded exercise
testing was conducted using the Bruce treadmill protocol on the Quinton 44000 stress
test system and Q55 treadmill (Quinton Instrument Co., Seattle, WA). Metabolic mea-
surements were taken with the Sensor Medics MMC Horizon System 4400 metabolic
cart (Sensor Medics, Anaheim, CA). Log books for daily recording of health problems
and exercise patterns were given to each subject at baseline. Heparinised whole blood
was used for NK cell number and activity assays and EDTA whole blood for complete
blood counts (CBC). CBC were performed on Coulter S-Plus IV instrumentation with
visual cell differentials in our clinical hematology laboratory”
STATISTICAL ANALYSIS: “results are expressed as mean ± SE. A 2 x 3 repeated mea-
sures ANOVAwith 1 between-participants factor (EX versus NEX) and 1 within-partic-
ipant factor (time of testing) was used to analyse the data. When Box’s M suggested that
the assumptions necessary for the univariate approach were not tenable, the multivariate
approach to repeated measures ANOVA was used. In the latter case, Pillais trace statistic
was used as the test statistic. With regard to comparison among specific means, only 7
comparisons were of interest to us. These were the contrast of the baseline measures with
the 6th and 15th week measurements within the EX and NEX groups and the contrast
between the EX and NEX groups at each of the 3 measurement points. The Dunn-
Sidak procedure was used to test these comparisons. Pearson correlations were used to
determine the association between change in cardiorespiratory fitness, NK cell activity
and URI symptomatology. Comparison between groups for age, BMI and URI were
evaluated by simple univariate t-tests”
Participants RECRUITMENT MEANS: not stated
TARGET PARTICIPANTS: premenopausal woman
N SCREENED: 50 mildly obese premenopausal woman
N COMPLETED: 36 completed; 18 (exercise) and 18 (control)
GENDER
F = 36; placebo 18, probiotic 18
AGE: exercise 36.0 (1.6); control 32.8 (1.4)
INCLUSIONCRITERIA: “25 to45 years of age,mildly obese (10%to40%overweight)
, premenopausal, 155 cm to 170 cm in height, not presently on an exercise programme
or a reducing diet, a non-smoker without a history of alcohol or drug abuse, no current
use of medications (except oral contraceptives), absence of hypertension and diabetes
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and no family history of heart disease”
BASELINE DETAILS: age, BMI, weight, compliance, NK cell response, metabolic
parameters including HR, VE and VO2
Interventions SETTING OF INTERVENTION: Loma Linda University Human performance Lab
DESCRIPTION OF INTERVENTION: for 15 weeks the EX group followed a closely
supervised walking programme on a measured course. This consisted of 5 sessions of
45 minute each week at an intensity of 60% of heart rate reserve. To ensure that the
participants exercised at a proper intensity, heart rates were monitored by checking pulse
rates every 0.8 km. At the completion of 45 min the supervisor recorded their walking
distance to the nearest 0.16km.During the 15-week study, theNEXgroupwas instructed
not to participate in any exercise outside of normal daily activity
DELIVERED BY: supervised exercises
FOLLOW-UP PERIOD:15 weeks
CO-INTERVENTIONS: the medication was kept constant during the study period
Outcomes Number of days with ARI; symptoms days per URI; NK cell response, metabolic pa-
rameters
FOLLOW-UP PERIOD: 15 weeks
Notes STUDY FUNDING: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The authors did not explain how the ran-
dom sequence was generated
Allocation concealment (selection bias) Unclear risk No description of how allocation was con-
cealed. “Those who qualified for the study
were instructed that they would be ran-
domly assigned to an exercise (EX) or non-
exercise (NEX) group”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were blinded to the study ob-
jectives, however more information was
needed
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
High risk Substantial loss to follow up: 28% drop-
outs, 8 at the beginning of the study and 6
during the study
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
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Other bias Low risk The study seems to be free from other
sources of bias
Nieman 1993
Methods STUDY DESIGN: parallel-group randomised controlled trial
LOCATION, NUMBER OF CENTRES: Appalachian State University
STUDY PERIOD: 12 weeks
METHODS OF ANALYSIS: “measurement of immune system variables and cardiores-
piratory fitness was conducted at baseline in both sedentary and highly conditioned el-
derly women. Following baseline testing, the 32 sedentary participants were randomly
assigned to either the experimental or control group and retested after both 5 and 12
weeks of exercise training. The 5-week testing was conducted to help determine if car-
diorespiratory and immune system changes occur early in response to a moderate ex-
ercise programme. Maximal oxygen uptake (VO2 max), weight and skin folds at the
biceps, triceps, subscapular and supra iliac sites were measured at baseline in highly con-
ditioned and sedentary participants and after 5 and 12 weeks of exercise training. Max-
imal graded treadmill testing using automated cardiorespiratory monitoring techniques
(MMC Horizon System Exercise Evaluation Cart, Sensormedics, Yorba Linda, CA) was
performed on all participants using a protocol developed in previous researchwith elderly
participants. Blood specimens were collected from all participants in the seated position
at 0700 hours after resting for a minimum of 10 minutes and abstaining from all food,
beverages (except water) and vigorous physical activity for at least 12 hours. Samples
were taken from the 32 sedentary participants at baseline and then again after 5 and
12 weeks of training. Samples from the 12 highly conditioned elderly participants were
taken only at baseline and from the 13 young women only at the 12-week testing. Rou-
tine complete blood counts (CBC) were performed using a Coulter STKS instrument
(Coulter Electronics, Inc., Hialeah, FL). Heparinised whole blood was used for immune
cell phenotyping for analysis of lymphocyte subset profiles”
STATISTICAL ANALYSIS: “results are expressed as means ± SE. Baseline comparisons
between the elderly and young females were made using simple univariate t-tests. A 2
x 3 repeated measures ANOVA with 1 between-participants factor (walking versus cal-
isthenic groups) and 1 within-subject factor (baseline, 5 and 12 week times for testing)
was used to analyse the training data. When Box’s M suggested that the assumptions
necessary for the univariate approach to repeated measures ANOVA was used. In the
latter case Pillais trace statistic was used as the test statistic. With regard to compari-
son among specific means, only 2 comparisons were of interest to us. These were the
contrast of the change in baseline measures with the 5th and 12th week measurements
between the walking and calisthenic groups. The Dunn-Sidak procedure was used to
test the comparisons. The chi-square test of association was used to test the relationship
between incidence of URTI and varying levels of cardiorespiratory exercise according to
group status (highly conditioned, walking and calisthenic groups) during the 12-week
study. The Pearson correlation coefficient was used to measure the linear correlationship
between immune function and physical fitness (aerobic power and sum of 4 skin-folds)
in all elderly women at baseline”
Participants RECRUITMENT MEANS: newspaper advertisements and direct mailings to local se-
nior citizen groups
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TARGET PARTICIPANTS: sedentary healthy elderly women
N RANDOMISED: 32 women
N COMPLETED: 30 completed; 14 (experimental) and 16 (control)
GENDER
F = 30
AGE: experimental 73.4 (1.1), control 73.5 (1.2)
INCLUSION CRITERIA: “between the ages of 67 and 85; did not smoke or abuse
alcohol; had not been on a reducing diet or exercise programme (≤ 3 moderate-to-
vigorous aerobic sessions of > 20-minute duration per week) for the previous 6 months;
were non-diseased (no current symptoms or signs suggestive of heart disease or cancer;
did not use medications known to affect immune function)”
BASELINE DETAILS: age, sex, height, weight, BMI, Sum of 4 skin-folds, VO2 max
Interventions SETTING OF INTERVENTION: university activity centre
DESCRIPTION OF INTERVENTION: “participants in both groups met at the uni-
versity activity centre and exercised 5 days/week, 30 to 40 minutes per session, under
supervision. Participants in the experimental group engaged in 5 sessions of 30-minute
to 40-minute brisk walking sessions per week at 60% of their heart rate reserve on either
an outdoor or indoor (during bad weather) track. Participants warmed up for 5 minutes
before each walking session with range-of-motion callisthenics. Total walking distances
were recorded by the supervisor and heart rates monitored every 10 minutes through
use of Polar pacer heart rate monitors (Polar USA, Inc.). Walking duration started at
30 minutes and was increased 2 minutes each week until participants were walking for
40 minutes by the mid-point of the study. Training heart rates were recalculated after
the 5-week testing to adjust for improvement in cardio-respiratory fitness and ensure
that subjects maintained the 60% intensity level. To control for subject expectations
and attention, the control group met in the same facility as the experimental group,
and engaged in mild flexibility and musculoskeletal calisthenics under the direction of a
second supervisor. Emphasis was placed on range-of-motion and stretching movements”
DELIVERED BY: supervised exercise
FOLLOW-UP PERIOD: 12 weeks
CO-INTERVENTIONS: none
Outcomes Leukocyte and lymphocyte subsets; natural killer cell activity; VO2 max; weight, sum of
4 skin-folds; incidence of upper respiratory tract infection
FOLLOW-UP PERIOD: 12 weeks
Notes STUDYFUNDING: this researchwas supported by a grant from theCybexCorporation
through the American College of Sports Medicine Foundation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The authors did not explain how the ran-
dom sequence was generated
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Allocation concealment (selection bias) Unclear risk No description of how allocation was con-
cealed; “randomised to either the experi-
mental or control groups”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The participants cannot be blinded due to
the nature of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There were 2 participants withmissing data
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
Other bias Low risk The study seems to be free from other
sources of bias
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Methods STUDY DESIGN: factorial randomised controlled trial
LOCATION, NUMBER OF CENTRES: Loma Linda University Center
STUDY PERIOD: late January to April
METHODS OF ANALYSIS: “log books for daily recording of health problems were
given to each participant at baseline. Careful verbal and written instructions were given
during a pre-study orientation session. Participants recorded health problems each day
of the 12-week study using codes used in previous studies. The coded health problems
included: 1. No health problems today; 2. Cold symptoms (runny, stuffy nose, sore
throat, coughing, sneezing, coloured discharge; 3. Flu symptoms (fever, headache, general
aches and pains, fatigue and weakness, chest discomfort, cough); 4. Nausea, vomiting
and/or diarrhoea; 5. Muscle, joint or bone problems/injury; 6. Other health problems
(describe). The severity of the symptoms was rated by participants as mild, moderate
or severe. The number of days with URTI symptoms was calculated for each subject,
with days counted only if 2 or more consecutive days of cold or flu symptoms were
reported with a mild to severe rating. Body mass and composition were determined for
all participants by means of underwater weighing. Residual volume was measured by the
nitrogen washout procedure using the System 2100 Computerized Pulmonary Function
Laboratory (Sensor Medics Corp, Yorba Linda, Calif ). Maximal aerobic power (Vo2
max) was determined using the Bruce graded maximal treadmill protocol (20). Oxygen
uptake was measured using the MedGraphics CPX metabolic system (MedGraphics
Corporation, St Paul, Minn). Immune assay measurement blood samples were drawn at
7 am from an antecubital vein with participants in the seated position (after 10 to 15
minutes of rest). Routine complete blood counts were performed by clinical haematology
laboratory staff using a Coulter STKS instrument (Coulter Electronics, Hialeah, Fla)”
STATISTICAL ANALYSIS: “statistical significance was set at the P value < 0.05 level
and values are expressed as mean ± standard deviation. Data analysed using a 4 (control,
exercise, diet, exercise+diet groups) x 2 (pre- and post-study) repeatedmeasures ANOVA.
Duncan multiple comparison test. Pearson product-moment correlations for changes in
body mass, body mass index, body fat mass and VO2 max”
Participants RECRUITMENTMEANS: participants were recruited from the surrounding commu-
nity through advertisements
TARGET PARTICIPANTS: obese females
N SCREENED: 102 obese females
N COMPLETED: 91 completed; 22 (control); 21 (exercise); diet (26); exercise + diet
(22)
GENDER
F = 91
AGE: 45.6 ± 1.1
INCLUSION CRITERIA: “between the ages of 25 and 75 years; in good health with
no known diseases, including diabetes, cancer and heart disease; body mass index (BMI,
calculated as kg/m2) between 25 and 65 for obese participants and less than 25 for non-
obese participants; not currently following a reducing diet or exercise programme not
using medications known to affect immune function; not using supplements in excess
of 100% of the Recommended Dietary Allowance on a regular basis; not experiencing
chronic pain, marked sleep disturbance, serious allergies, salient emotional or mood
problems; no recent history of systemic infection, bone fracture, or surgery; and not
smoking cigarettes or abusing alcohol”
BASELINE DETAILS: compliance, body composition and immune function, blood
cholesterol, triglycerides and glucose
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Interventions SETTING OF INTERVENTION: indoor track
DESCRIPTION OF INTERVENTION: participants in 2 exercise groups (E and ED)
were required towalk 5 times aweek, 45minutes per session, at 60% to 80%ofmaximum
heart rate (MHR), for 12 weeks (60 total exercise sessions). Supervised sessions were
held 4 days per week at an indoor track with duration, heart rate and distance walked
measured and recorded. Participants walked 1 session per week without supervision.
Duration and intensity of exercise was gradually increased over a 3-week period from 25
to 30 minutes/session at 60% to 65%MHR during the first week to 45 minutes at 70%
to 80% MHR from weeks 4 to 12. Participants in the 2 non-walking groups (C and D)
reported to the exercise facility 4 days week for a 45-minute session of stretching and
mild range-of-motion callisthenic exercises
DELIVERED BY: supervised sessions
FOLLOW-UP PERIOD: 12 weeks
CO-INTERVENTIONS: none
Outcomes Body composition, aerobic power and immune function, blood cholesterol, triglycerides
and glucose, days of URTI
FOLLOW-UP PERIOD: 12 weeks
Notes STUDY FUNDING: this work was funded by The Cybex Grant from the American
College of Sports Medicine
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The authors did not explain how the ran-
dom sequence was generated
Allocation concealment (selection bias) Unclear risk No description of how allocation was con-
cealed. “Before being included in the study,
participants had to agree to be randomised
to any 1 of the 4 groups (control, exercise,
diet, diet and exercise)”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
High risk There was loss of 10.8% (drop-outs) and
no intention-to-treat analysis was used
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
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Other bias Low risk The study seems to be free from other
sources of bias
Sloan 2013
Methods STUDY DESIGN: prospective randomised controlled trial
LOCATION, NUMBER OF CENTRES: information not provided
STUDY PERIOD: information not provided
METHODS OF ANALYSIS: “each participant visited the exercise physiology labora-
tory before the first experimental test session for screening purposes and to familiarise
themselves with the laboratory testing procedures. At this session, participants also pro-
vided written informed consent. During this preliminary visit participants underwent
the same test procedures that were used during subsequent graded maximal exercise test-
ing except that the graded exercise test protocol was stopped once a participant reached
an exercise intensity level corresponding to 75% of her age-predicted maximal heart rate
(HR max = 220 - age) and successfully demonstrated the ability to maintain this level of
exercise intensity for 30 minutes without becoming unduly fatigued”
Inclusion criteria for participant selectionwere: “(1) female; (2) 1 to 5 years since cessation
of menses; (3) FSH levels > 40 IU/L; (4) not on oestrogen replacement therapy; (5)
sedentary, defined as no participation in a regular exercise programme for 2 or more
times per week for at least 20 minutes per session or in a participative sport at least twice
per week during the preceding 6 months; (6) written clearance from personal primary
health care provider to participate in the study; and (7) willingness to accept random
assignment”
STATISTICAL ANALYSIS: “using a 2 sample t test, the differences in the mean EG and
CG at baseline on key demographic variables of age, height, weight, body mass index
(BMI), FSH and VO2 max between the 2 groups were evaluated. The distributions of
all obtained measures were plotted graphically for visual inspection regarding deviation
from normality. The result of the Shapiro-Wilk Test for Normality indicated that the
null hypothesis for normality assumptions of mucosal immune measures could not be
rejected. The mucosal immune measures data were analysed using multivariate repeated
measures analysis of variance (ANOVA). To compare the difference in outcome variables
from the baseline and subsequentmeasurements, the contrast and profile transformations
in repeated-measures ANOVA were employed. A P value of < 0.05 was considered
statistically significant. For simultaneous testing of hypotheses, the Bonferroni method
for controlling the overall error rate was used. All statistical analysis was performed using
Statistical Analysis System (SAS, version 9.2) software. Values have been shown as means
± standard deviations”
Participants RECRUITMENT MEANS: information not provided
TARGET PARTICIPANTS: healthy post-menopausal women
N SCREENED: 32 participants
N COMPLETED: 32 participants
GENDER
F = 32; intervention 16, control 16
AGE: 54.1 ± 5.3 years old
BASELINE DETAILS: age, gender, physical activity profile, symptom checklist, health
history, immune deficiency, medications
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Interventions SETTING OF INTERVENTION: home-based walking programme
DESCRIPTION OF INTERVENTION: 5 days/week of 30-minute brisk walking at
a prescribed moderate aerobic exercise intensity corresponding to 75% of individual
HRmax
DELIVERED BY: self delivered
INTERVENTION PERIOD: 16 weeks
CO-INTERVENTIONS: none described
Outcomes Height, weight, BMI, FSH, VO2max, VE max, RER max, HR max, SIgA measures,
incidence and duration of URTI
FOLLOW-UP PERIOD: 16 weeks
Notes STUDY FUNDING: Supported by NIH/NINR R01 NR 008024
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The authors mention randomisation, but
they do not describe it
Allocation concealment (selection bias) Unclear risk The authors do not describe how partic-
ipants were allocated. “Following random
assignment to the EG or CG ...”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was no loss to follow-up
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
Other bias Low risk The study seems to be free from other
sources of bias
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Methods STUDY DESIGN: randomised controlled trial
LOCATION, NUMBER OF CENTRES: School of Physical Education at Ball State
University
STUDY PERIOD: 6 exercise sessions in a 10-day period
METHODS OF ANALYSIS: “all participants reported to the laboratory every 12 hours
for 10 consecutive days. Beginning on day 2 (the day of the second inoculation), all
participants completed a 13-item symptom severity checklist for each reporting period
for virus detection and quantification. Just beforeHRV 16 inoculation, a pre-inoculation
nasal wash was taken from all participants. This nasopharyngeal sample, designed to de-
tect most subclinical or incubating respiratory viruses, allowed us to eliminate previously
infected participants from the experiment. The cultures were examined by microscope
approximately every other day; other standard techniques were used for detection and
identification of viruses (e.g. hemadsorption for myxo and paramyxoviruses, acid lability
for rhinoviruses, etc.). These cell cultures could not detect all possible viruses (e.g. most
coronavirus infections and many coxsackie A viruses). Beginning the day after inocu-
lation (day 2), nasal washings were obtained and virus specimens were quantitated for
HRV 16. Instruments included cycling on either the Air-Dyne bicycle (Schwinn Bicycle
Co., Chicago, IL) or Cybex MET 100 cycle (Cybex Metabolic Systems, Ronkonkoma,
NY); walking or jogging on a treadmill (Trotter, Millis, MA) or at an indoor track; or
stair climbing on the Stepmill (Stair Master Sports andMedical Products, Kirkland,WA)
. All participants performed the same mode for each training session. HR was monitored
continuously via Polar HR telemetry units; rating of perceived exertion via the Borg 6-
20 RPE scale was recorded twice per training session”
STATISTICAL ANALYSIS: “symptom severity scores from the cold symptom checklist
were summed. 3 statistical analysis were performed. A 2 group by 9 measure (2 × 9)
repeated measures ANOVA procedure was used to compare the symptom questionnaire
mean z-value scores and the mucous weights for days 2 to 10. A participant’s values
obtained during the a.m. and p.m. testing were averaged to arrive at a participant’s value
for a day. The statistical power for comparing the differences between the EX and NEX
groups over the 9 days (P value < 0.05) was 0.96 for Cohen’s medium-sized effect (Eta =
0.25) and 0.99 for his large effect (Eta = 0.37). Preliminary analyses of the questionnaire
and mucous data suggested an alternative to the usual ANOVA procedure was desirable.
The alternative procedure employed for these data was the assignment of ranks to the
data values, normalising the ranks (obtaining normal distribution z-values for percentiles
of the ranks) and evaluating the data via conventional ANOVA procedures and F-tests.
The other 2 statistical procedures were a 2 by 5 (2 × 5) repeated measures ANOVA for
differences between the EX pre- and post-exercise cold symptom scores and a one-way
ANOVA for differences between the quantity of recreational physical activity performed
by the EX and NEX groups. The statistical power for the EX group pre post differences
(P value < 0.05) was 0.67 for Cohen’s medium-sized effect (Eta = 0.25) and 0.97 for his
large effect (Eta = 0.37). The SPSS MANOVA program (SPSS, Inc., Chicago, IL) was
used for these analyses”
Participants RECRUITMENT MEANS: student volunteers solicited from classes
TARGET PARTICIPANTS: healthy adults
N SCREENED: 50 adult students
N RANDOMISED: 50 adults randomised
N COMPLETED: 50 adults completed the study; 34 (intervention group) and 16
(control group)
GENDER
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M = 24; intervention 17, control 7
F = 14; intervention 17, control 9
AGE: 19 to 29 years old
BASELINE DETAILS: age, gender, physical activity profile, symptom checklist, health
history, immune deficiency, medications
Interventions SETTING OF INTERVENTION: Ball State University, School of Physical Education
laboratory
DESCRIPTION OF INTERVENTION: “2 standardised incremental treadmill proto-
cols, 1 for men and 1 for women, were used in this study. Both protocols consisted of
1-minute stages (1-MET increments) and began with 5 to 6 minutes of graded walk-
ing and then progressed to running speeds. All participants were encouraged to give a
maximal effort and were provided with strong verbal prompts throughout the testing
sessions. HR and RPE were recorded during the last 10 seconds of each stage. Exercise
training. Within 18 hours of the first inoculation, EX participants began the supervised
exercise training programme previously described. Participants were scheduled for 1 of
2 possible exercise times, either morning or evening. Participants who were assigned to
exercise in the morning were expected to exercise at the same time for the entire 6 days
of training; likewise, participants assigned to exercise in the evening did so regularly.
Exercise consisted of training at 70% of HR reserve for 40 minutes, with the mode of
exercise designed to match each participant’s regular form of workout. Choices included
cycling on either the Air-Dyne bicycle (Schwinn Bicycle Co., Chicago, IL) or Cybex
MET 100 cycle (Cybex Metabolic Systems, Ronkonkoma, NY); walking or jogging on
a treadmill (Trotter, Millis, MA) or at an indoor track; or stair climbing on the Stepmill
(StairMaster Sports and Medical Products, Kirkland, WA). All participants performed
the same mode for each training session. HR was monitored continuously via Polar HR
telemetry units; rating of perceived exertion via the Borg 6-20 RPE scale was recorded
twice per training session”
DELIVERED BY: supervised by the researchers
INTERVENTION PERIOD: 10 days
CO-INTERVENTIONS: rhinovirus induced disease
Outcomes Cold symptom, upper respiratory infection and severity of disease measured by ques-
tionnaire and facial tissues
FOLLOW-UP PERIOD: 10 days
Notes STUDY FUNDING: this research was supported by NIH HL 50123
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The authors did not explain how the ran-
dom sequence was generated
Allocation concealment (selection bias) Unclear risk No description of how allocation was con-
cealed. “Fifty subjects who tested negative
to the HRV 16 antibody were randomly
assigned to the exercise (EX) group or the
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non-exercise (NEX) group”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was no loss to follow-up
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
Other bias Low risk The study seems to be free from other
sources of bias
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Methods STUDY DESIGN: quasi-randomised controlled trial
LOCATION, NUMBER OF CENTRES: School of Physical Education at Ball State
University
STUDY PERIOD: 7 days
METHODS OF ANALYSIS: “volunteers were interviewed about their physical activity
levels and completed a 13-item symptom severity checklist as part of the initial screening
process. A physical examination by a doctor and screening included a health history
questionnaire about acute and chronic diseases, asthma, bronchitis, chronic colds, aller-
gies, pregnancy, immune deficiency, medications, smoking and physical activity level.
Volunteers were sedentary (2 or fewer days a week of recreational exercise for less than
30 minutes a day for the preceding 3 months). Participants had no symptoms of lower
respiratory tract illness, were afebrile (< 100°F) and apparently healthy according to the
criteria of the American College of Sports Medicine. All participants agreed to refrain
from self treating their colds with over the counter medicines. Each participant signed
an informed consent form approved by the institutional review board. Participants who
completed the study received some remuneration. All participants reported to the labo-
ratory every 12 hours (0700 and 1900) for 7 consecutive days, beginning on the evening
of the day on which they were selected into the study. All completed the 13-item symp-
tom severity checklist at each reporting period. They all also completed an activity log
during each evening reporting period to monitor their physical activity levels. After the
seventh day of the study, participants reported to the laboratory once a day until they
were asymptomatic”
STATISTICAL ANALYSIS: “symptom severity scores from the cold symptom checklist
were summed. 2 statistical analyses were performed. A 2 group (EX and NEX) by 2
factor repeated measures analysis of variance was used to compare the mean symptom
questionnaire values of study participants for mornings and evenings (AM/PM) of 6 time
periods (DAY) after collection of the baseline symptom data (2 x 2 x 6). The analyses
included data obtained for only days 2 to 7 of the study because some study participants
were unable to participate on the first day after collection of the baseline data. An
independent groups t test was used to compare the number of days from baseline until
the study participants were symptom free. The analysis of variance was performed on
scores obtained by: (a) subtracting baseline symptom values from values obtained during
the study; (b) ranking the resulting difference values; and (c) obtaining normalised z
scores for the ranks. A set of polynomial contrasts was specified in the SPSS MANOVA
program (SPSS, Inc, Chicago, Illinois, USA) for the day factor. Statistical tests were
conducted for the linear relation component of elapsed time from baseline scores and for
the relations of the other components combined with the scores. The latter statistical test
identified if systematic variation among the score means existed beyond that identified
by the linear component - that is, deviation from linearity. The statistical power for
evaluating the relation of the day factor with the scores and for the difference between
the EX and NEX groups over the days (P value < 0.05) was 0.89 for Cohen’s large effect
size and 0.45 for his medium effect size (x). A 1 way analysis of variance for differences
between the measures on the physical activity logs for the EX and NEX groups was also
completed. A P value < 0.05 was considered significant in this investigation”
Participants RECRUITMENT MEANS: newspaper advertisements
TARGET PARTICIPANTS: students that acquired a URTI within the preceding 3 to
4 days (typical peak of illness)
N RANDOMISED: 22 adult students
N COMPLETED: 22 adults completed the study; 11 (intervention group) and 11
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(control group)
GENDER
M = 7; intervention 4, control 3
F = 15; intervention 7, control 8
AGE: ages 19 to 29 years old
BASELINE DETAILS: age, gender, physical activity profile, symptom checklist, health
history, immune deficiency, medications
Interventions SETTING OF INTERVENTION: Ball State University, School of Physical Education
laboratory
DESCRIPTION OF INTERVENTION: “by the second day of the study, participants
in the EX group began the supervised exercise training sessions. They were scheduled
for either a morning or an evening exercise session and were expected to exercise at the
same time for all 5 days of the study. Exercise sessions lasted 30 minutes at 70% of
target heart rate with the mode of exercise chosen by the participant from the following
list of choices: the Air-Dyne bicycle (Schwinn Bicycle Co, Chicago, Illinois, USA); the
Cybex MET 100 cycle (Cybex Metabolic Systems, Ronkonkoma, New York, USA);
walking or jogging on a treadmill (Trotter, Millis, Massachusetts) or on an indoor track;
or stair climbing on the Stepmill (StairMaster Sports and Medical Products, Kirkland,
Washington, USA). All participants performed the same mode for each training session.
Heart rate was monitored continuously via Polar heart rate telemetry units”
DELIVERED BY: supervised by the researchers
INTERVENTION PERIOD: 7 days
CO-INTERVENTIONS: none
Outcomes Symptom severity/duration
FOLLOW-UP PERIOD: until the end of symptoms
Notes STUDY FUNDING: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk The participants were alternately assigned
to either group
Allocation concealment (selection bias) High risk The allocation to group was predictable
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The participants cannot be blinded due to
the characteristics of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes measured by participant self re-
port
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was no loss to follow-up
43Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Weidner 2003 (Continued)
Selective reporting (reporting bias) Unclear risk The study protocol is not available, so we
do not have enough information to judge
Other bias Low risk The study seems to be free from other
sources of bias
°F: Fahrenheit
Albs: salivary albumin
ANCOVA: analysis of covariance
ANOVA: analysis of variance
ARI: acute respiratory infection
BMI: body mass index
C3: complement 3
C4: complement 4
CBC: complete blood counts
CG: control group
CTSA: Clinical and Translational Science Award
EG: exercise group
EKG: electrocardiogram
ELISA: enzyme linked immunosorbent assay
Eta: eta-squared values from multifactor ANOVA
EX: exercise
FSH: follicle-stimulating hormone
HR: heart rate
IgA: immunoglobulin A
IgG: immunoglobulin G
IgM: immunoglobulin M
IL-8: interleukin-8
IPAQ: International Physical Activity Questionnaire
LOT: Life Orientation Test
MAAS: Mindful Attention Awareness Scale
MBSR: mindfulness-based stress reduction
MET: Metabolic Equivalent of Task
NEX: non-exercise
NIH: National Institutes of Health
NK: natural killer
PANAS: positive and negative affect schedule
PR: positive relationships
PSQI: Pittsburgh Sleep Quality Index
PSS-10: perceived stress scale
RER: respiratory exchange ratio
SD: standard deviation
SE: standard error
SF-12: short form 12
SIgA: salivary immunoglobulin A
SPSS: statistical package for the social sciences
STAI: State Trait Anxiety Inventory
URI: upper respiratory infection
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URTI: upper respiratory tract infection
VE: pulmonary ventilation
VO2: oxygen uptake
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bergendiova 2011 RCT focusing on supplementation and not exercise
Biondo 2010 RCT focusing on supplementation and not exercise
Constantini 2011 RCT focusing on supplementation and not exercise
Cox 2007 RCT focusing on supplementation and not exercise
Cox 2010 RCT focusing on supplementation and not exercise
Henson 2008 RCT focusing on supplementation and not exercise
Kekkonen 2007 RCT focusing on supplementation and not exercise
Meyer 2004 The focus of the intervention was regeneration regimens and not exercise
Nieman 2002 RCT focusing on supplementation and not exercise
Peters 1993 RCT focusing on supplementation and not exercise
Rall 1996 This study did not analyse the condition acute respiratory infection
Shing 2007 RCT focusing on supplementation and not exercise
Spence 1990 This study did not analyse the condition acute respiratory infection
Tiollier 2005 This study did not analyse the condition acute respiratory infection
Weidner 1997 The participants were inoculated with HRV 16
West 2011 RCT focusing on supplementation and not exercise
Yang 2007 This is not a randomised controlled trial
Yang 2008 This is not a randomised controlled trial
RCT: randomised controlled trial
HRV: human rhinovirus type 16
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D A T A A N D A N A L Y S E S
Comparison 1. Exercise versus control intervention for acute respiratory infections (total)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of ARI episodes per
person/year
2 213 Rate Ratio (Random, 95% CI) 0.91 [0.59, 1.42]
2 Proportion of people who
experienced at least one ARI
over study period
3 219 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.57, 1.01]
3 Severity of ARI 1 98 Mean Difference (IV, Random, 95% CI) -110.0 [-323.53,
103.53]
4 Number of symptom days in the
follow-up period (12 weeks)
3 208 Mean Difference (IV, Random, 95% CI) -2.06 [-4.39, 0.27]
5 Number of symptom days per
episode
4 256 Mean Difference (IV, Random, 95% CI) -1.13 [-1.71, -0.54]
6 Laboratory parameters -
lymphocytes
3 157 Mean Difference (IV, Random, 95% CI) 0.11 [-0.10, 0.31]
7 Laboratory parameters - IgA 4 166 Std. Mean Difference (IV, Random, 95% CI) 0.07 [-0.37, 0.52]
8 Laboratory parameters -
neutrophils
3 214 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.44, 0.22]
9 Quality of life 1 Mean Difference (IV, Random, 95% CI) Totals not selected
9.1 Physical health 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
9.2 Mental health 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
10 Cost to the patient (USD) 1 Mean Difference (IV, Random, 95% CI) Subtotals only
11 Exercise-related injuries 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
12 Adherence to the group
intervention
8 499 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.95, 1.02]
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Analysis 1.1. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 1 Number of ARI episodes per person/year.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 1 Number of ARI episodes per person/year
Study or subgroup Exercise non-exercise log [Rate Ratio] Rate Ratio Weight Rate Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Barrett 2012 47 51 -0.3524 (0.25) 41.9 % 0.70 [ 0.43, 1.15 ]
Chubak 2006 53 62 0.100388 (0.17157) 58.1 % 1.11 [ 0.79, 1.55 ]
Total (95% CI) 100 113 100.0 % 0.91 [ 0.59, 1.42 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 2.23, df = 1 (P = 0.14); I2 =55%
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 2 Proportion of people who experienced at least one ARI over study period.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 2 Proportion of people who experienced at least one ARI over study period
Study or subgroup Exercise Non-exercise Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barrett 2012 17/47 28/51 30.3 % 0.66 [ 0.42, 1.04 ]
Chubak 2006 28/42 38/49 63.5 % 0.86 [ 0.66, 1.12 ]
Nieman 1993 3/14 8/16 6.1 % 0.43 [ 0.14, 1.31 ]
Total (95% CI) 103 116 100.0 % 0.76 [ 0.57, 1.01 ]
Total events: 48 (Exercise), 74 (Non-exercise)
Heterogeneity: Tau2 = 0.01; Chi2 = 2.49, df = 2 (P = 0.29); I2 =20%
Test for overall effect: Z = 1.90 (P = 0.057)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Exercise Non-exercise
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Analysis 1.3. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 3 Severity of ARI.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 3 Severity of ARI
Study or subgroup Exercise Non-exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Barrett 2012 47 248 (582.4032) 51 358 (487.1033) 100.0 % -110.00 [ -323.53, 103.53 ]
Total (95% CI) 47 51 100.0 % -110.00 [ -323.53, 103.53 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 4 Number of symptom days in the follow-up period (12 weeks).
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 4 Number of symptom days in the follow-up period (12 weeks)
Study or subgroup Exercise Non-exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Barrett 2012 47 2.19 (4.99) 51 3.65 (5.79) 51.7 % -1.46 [ -3.60, 0.68 ]
Klentrou 2002 9 11 (8.8714) 10 8.65 (7.7595) 8.7 % 2.35 [ -5.18, 9.88 ]
Nieman 1997 43 5.6 (5.9) 48 9.4 (7.6) 39.7 % -3.80 [ -6.58, -1.02 ]
Total (95% CI) 99 109 100.0 % -2.06 [ -4.39, 0.27 ]
Heterogeneity: Tau2 = 1.55; Chi2 = 3.12, df = 2 (P = 0.21); I2 =36%
Test for overall effect: Z = 1.73 (P = 0.083)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 5 Number of symptom days per episode.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 5 Number of symptom days per episode
Study or subgroup Exercise Non-exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Nieman 1990 18 3.6 (2.9698) 18 7 (5.9397) 3.6 % -3.40 [ -6.47, -0.33 ]
Barrett 2012 47 9.3 (5.13) 51 11.4 (5.75) 7.1 % -2.10 [ -4.25, 0.05 ]
Sloan 2013 16 5.3 (1.5) 16 6.3 (2.2) 18.0 % -1.00 [ -2.30, 0.30 ]
Cilo lu 2005 60 5.15 (1.5575) 30 6.1 (1) 71.4 % -0.95 [ -1.48, -0.42 ]
Total (95% CI) 141 115 100.0 % -1.13 [ -1.71, -0.54 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 3.30, df = 3 (P = 0.35); I2 =9%
Test for overall effect: Z = 3.78 (P = 0.00016)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 6 Laboratory parameters - lymphocytes.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 6 Laboratory parameters - lymphocytes
Study or subgroup Exercise Non-exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Nieman 1990 18 2.24 (0.6788) 18 2.35 (0.5515) 23.2 % -0.11 [ -0.51, 0.29 ]
Nieman 1993 14 2.6 (0.898) 16 2.19 (0.68) 11.9 % 0.41 [ -0.17, 0.99 ]
Nieman 1997 43 2.126 (0.5701) 48 2 (0.4906) 64.9 % 0.13 [ -0.09, 0.35 ]
Total (95% CI) 75 82 100.0 % 0.11 [ -0.10, 0.31 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 2.21, df = 2 (P = 0.33); I2 =10%
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 7 Laboratory parameters - IgA.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 7 Laboratory parameters - IgA
Study or subgroup Exercise Non-exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cilo lu 2005 60 26.5 (8.46) 30 27.4 (12.4) 38.3 % -0.09 [ -0.53, 0.35 ]
Klentrou 2002 9 373.5 (243.3) 10 186.2 (164.4384) 16.2 % 0.87 [ -0.08, 1.82 ]
Manzaneque 2004 12 175.5 (84.2) 13 219.5 (99.7) 20.8 % -0.46 [ -1.26, 0.34 ]
Sloan 2013 16 179.5 (43.3) 16 167.7 (46.1) 24.6 % 0.26 [ -0.44, 0.95 ]
Total (95% CI) 97 69 100.0 % 0.07 [ -0.37, 0.52 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 5.14, df = 3 (P = 0.16); I2 =42%
Test for overall effect: Z = 0.33 (P = 0.74)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 8 Laboratory parameters - neutrophils.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 8 Laboratory parameters - neutrophils
Study or subgroup Exercise Non-exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Barrett 2012 47 103.7 (512.2424) 51 110.4 (311.1061) 43.9 % -0.02 [ -0.41, 0.38 ]
Manzaneque 2004 12 2.85 (1.0254) 13 3.63 (1.0254) 14.4 % -0.74 [ -1.55, 0.08 ]
Nieman 1997 43 3.6 (1.0082) 48 3.6 (1.0543) 41.8 % 0.00 [ -0.41, 0.41 ]
Total (95% CI) 102 112 100.0 % -0.11 [ -0.44, 0.22 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 2.74, df = 2 (P = 0.25); I2 =27%
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 9 Quality of life.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 9 Quality of life
Study or subgroup Exercise Non-exercise
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Physical health
Barrett 2012 47 52 (8.8553) 51 50.6 (9.9554) 1.40 [ -2.32, 5.12 ]
2 Mental health
Barrett 2012 47 49.7 (10.2176) 51 46.3 (9.9554) 3.40 [ -0.60, 7.40 ]
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Analysis 1.10. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 10 Cost to the patient (USD).
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 10 Cost to the patient (USD)
Study or subgroup Exercise Non-exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Barrett 2012 47 136 (293) 51 214 (416) -78.00 [ -219.60, 63.60 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
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Analysis 1.11. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 11 Exercise-related injuries.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 11 Exercise-related injuries
Study or subgroup Exercise Non-exercise Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Nieman 1993 2/14 0/16 5.67 [ 0.29, 108.91 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 2 (Exercise), 0 (Non-exercise)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
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Analysis 1.12. Comparison 1 Exercise versus control intervention for acute respiratory infections (total),
Outcome 12 Adherence to the group intervention.
Review: Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections
Comparison: 1 Exercise versus control intervention for acute respiratory infections (total)
Outcome: 12 Adherence to the group intervention
Study or subgroup Exercise Non-exercise Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barrett 2012 47/51 51/52 14.9 % 0.94 [ 0.86, 1.03 ]
Chubak 2006 42/53 49/62 3.3 % 1.00 [ 0.83, 1.21 ]
Cilo lu 2005 60/60 30/30 46.0 % 1.00 [ 0.95, 1.05 ]
Klentrou 2002 9/10 10/10 1.6 % 0.90 [ 0.69, 1.18 ]
Manzaneque 2004 13/16 13/13 1.7 % 0.82 [ 0.63, 1.07 ]
Nieman 1990 18/25 18/25 1.0 % 1.00 [ 0.71, 1.41 ]
Nieman 1993 14/16 16/16 2.6 % 0.88 [ 0.71, 1.09 ]
Sloan 2013 30/30 30/30 28.9 % 1.00 [ 0.94, 1.07 ]
Total (95% CI) 261 238 100.0 % 0.98 [ 0.95, 1.02 ]
Total events: 233 (Exercise), 217 (Non-exercise)
Heterogeneity: Tau2 = 0.0; Chi2 = 6.38, df = 7 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Characteristics of included studies - baseline
ID/location/full publi-
cation
n randomised/ with-
drawals
% Female Age Information regarding participants
Manzaneque 2004/
Spain/yes
29/3 51.7 18 to 21 years Healthy, sedentary
Weidner 1998/USA/yes 50/0 52 19 to 29 years Moderately fit, maximal oxygen uptake
value corresponding to > the 40th per-
centile for age and gender
Barrett 2012/USA/yes 154/5 81,8 50 years or older Healthy, sedentary
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Table 1. Characteristics of included studies - baseline (Continued)
Chubak 2006/USA/yes 115/0 100 50 years or older Overweight/obese, non-smoking, seden-
tary, post-menopausal women
Weidner 2003/USA/yes 25/0 68.1 19 to 29 years Sedentary
Nieman 1993/USA/yes 32/2 100 67 to 85 years Healthy, sedentary
Cilo lu 2005/Turkey/
yes
90/0 100 45 to 65 years Post-menopausal sedentary women
Klentrou 2002/Canada/
yes
20/0 Not reported 25 to 50 years Sedentary men or women
Nieman 1990/USA/yes 50/14 100 25 to 45 years Mildly obese, sedentary women
Nieman 1997/USA/yes 102/11 100 25 to 70 years Obese, sedentary women
Sloan 2013/USA/yes 32/0 100 54.1 ± 5.3 years Healthy, post-menopausal women
ID: study citation
USA: United States of America
ARI: acute respiratory infection
Table 2. Characteristics of exercise interventions for ARI
ID/
location/ full
publication
Type of exer-
cise
Frequency Intensity Duration Supervision Comparison
group
Outcomes in
meta-analysis
Manzaneque
2004/Spain/
yes
Qigong 5 days per
week
8
distinct move-
ments re-
peated 8 times
to 30 minutes
4 weeks Qualified
qigong instruc-
tor
Non-exercise Adherence
Weidner
1998/USA/
yes
Exercise 6 days of exer-
cise
70%ofHRre-
serve
10 days Supervised
training
Non-exercise Adherence;
ARI symptoms
Barrett 2012/
USA/yes
Bicycle, tread-
mill and brisk
walk
One
group contact
(2.5 hours per
week)
+ 45 minutes
home practice
per day
12 to 16 Borg
Scale
8 weeks Supervised by
exercise physi-
ologist
Meditation and
non-exercise
Adherence;
ARI episodes;
ARI symptoms
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Table 2. Characteristics of exercise interventions for ARI (Continued)
Chubak
2006/USA/
yes
Bicycle, tread-
mill or walk
5 days per
week
45 minutes of
moderate-
intensity exer-
cise
12 months Supervised by
exercise physi-
ologist in the
first 3 months
Once-weekly,
45-
minute stretch-
ing sessions
Adherence;
ARI episodes
Weidner
2003/USA/
yes
Bicycle, walk-
ing or jogging
5 days per
week
30 minutes at
70% of target
heart rate
7 days Supervised Non-exercise Adherence
Nieman
1993/USA/
yes
Brisk walking 5 days per
week
30
to 40 minutes
at 60% target
heart rate
12 weeks Supervised Callisthenics Adherence;
ARI episodes;
lymphocytes
Cilo lu 2005/
Turkey/yes
Walking on a
treadmill or an
outdoor tract
5 days per
week
30 min-
utes each time
respectively at
60% MHR
12 weeks Supervised Outdoor exer-
cise and non-
exercise
Adherence;
ARI symptoms
Klentrou
2002/
Canada/yes
Bicycles,
treadmills,
stair climbers
or combined
3 days per
week
30 minutes at
75% HR re-
serve
+ 15 minutes
stretching
12 weeks Supervised Non-exercise Adherence;
ARI
symptoms; sali-
vary secretion
immunoglobu-
lin.
Nieman
1990/USA/
yes
Walking 5 days per
week
45 minutes
at 60% reserve
heart rate
15 weeks Supervised Non-exercise Adherence;
ARI episodes;
ARI symp-
toms; lympho-
cytes
Nieman
1997/USA/
yes
Walking 5 days per
week
45 minutes at
60%
to 80% reserve
heart rate
12 weeks Supervised Non-exercise Adherence;
ARI symp-
toms; lympho-
cytes
Sloan 2013/
USA/yes
Walking 5 days per
week
30 min-
utes at 75% of
individual HR
max
16 weeks Not supervised Non-exercise ARI episodes;
adherence; ARI
symptoms; sali-
vary secretion
immunoglobu-
lin
ID: study citation
USA: United States of America
HR: heart rate
ARI: acute respiratory infection
NK: natural killer
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A P P E N D I C E S
Appendix 1. MEDLINE (OVID)
1 respiratory tract infections/ or bronchitis/ or common cold/ or influenza, human/ or laryngitis/ or exp pharyngitis/ or exp pneumonia/
or exp sinusitis/
2 (respiratory adj2 (infect* or illness or symptom* or acute or virus*)).tw.
3 (common cold* or colds or coryza).tw.
4 ((acute or viral or virus* or bacter*) adj2 rhinit*).tw.
5 (influenza* or flu or ili).tw.
6 (pharyngit* or laryngit* or tonsillit* or sore thoat*).tw.
7 (throat* adj3 (infect* or inflam*)).tw.
8 (nasopharyngit* or rhinopharyngit*).tw.
9 Cough/
10 cough*.tw.
11 (sinusit* or rhinosinusit* or nasosinusit*).tw.
12 (bronchit* or pneumon* or bronchopneumon* or pleuropneumon*).tw.
13 (ari or urti or lrti).tw.
14 or/1-13
15 exp Exercise/
16 exp Exercise Movement Techniques/
17 exp Exercise Therapy/
18 Physical Fitness/
19 physical endurance/ or exercise tolerance/
20 Physical Exertion/
21 exp Sports/
22 Dancing/
23 (exercis* or sport* or fitness* or gym* or aerobic*).tw.
24 ((weight* or strength* or enduranc* or circuit*) adj5 (program* or train* or session*)).tw.
25 (physical* adj5 (fit* or activ* or movement* or train* or condition* or program*)).tw.
26 (activ* adj2 life*).tw.
27 (run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or
qi gong).tw.
28 or/15-27
29 14 and 28
Appendix 2. EMBASE (Elsevier) search strategy
#37 #25 AND #36 27022
#36 #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 1390178
#35 run*:ab,ti OR walk*:ab,ti OR jog*:ab,ti OR sprint*:ab,ti OR treadmill*:ab,ti OR row*:ab,ti OR swim*:ab,ti OR bicycl*:ab,ti OR
cycl*:ab,ti OR danc*:ab,ti OR yoga:ab,ti OR ’tai chi’:ab,ti OR ’tai ji’:ab,ti OR qigong:ab,ti OR ’qi gong’:ab,ti AND [embase]/lim
976799
#34 (activ* NEAR/2 life*):ab,ti AND [embase]/lim 5574
#33 (physical* NEAR/5 (fit* OR activ* OR movement* OR train* OR condition* OR program*)):ab,ti AND [embase]/lim 74609
#32 ((weight* OR strength* OR enduranc* OR circuit*) NEAR/5 (program* OR train* OR session*)):ab,ti AND [embase]/lim 18505
#31 exercis*:ab,ti OR sport*:ab,ti OR fitness*:ab,ti OR gym*:ab,ti OR aerobic*:ab,ti AND [embase]/lim 267006
#30 ’sport’/exp AND [embase]/lim 58241
#29 ’training’/de OR ’endurance’/de OR ’exercise tolerance’/de OR ’physical capacity’/de AND [embase]/lim 78874
#28 ’physical activity’/exp OR ’physical activity, capacity and performance’/de AND [embase]/lim166092
#27 ’kinesiotherapy’/exp AND [embase]/lim 29817
#26 ’exercise’/exp AND [embase]/lim 140065
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#25 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR
#17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 427944
#24 (throat* NEAR/3 (infect* OR inflam*)):ab,ti AND [embase]/lim 750
#23 cough*:ab,ti AND [embase]/lim 34249
#22 ’coughing’/de AND [embase]/lim 46685
#21 influenza*:ab,ti OR ’flu’/de OR ili:ab,ti AND [embase]/lim 75233
#20 ’influenza’/exp AND [embase]/lim 38070
#19 ((acute OR viral OR virus* OR bacter*) NEAR/2 rhinitis):ab,ti AND [embase]/lim 263
#18 ’common cold’:ab,ti OR ’common colds’:ab,ti OR colds:ab,ti OR coryza:ab,ti AND [embase]/lim 3569
#17 ’common cold’/de OR ’common cold symptom’/de AND [embase]/lim 4712
#16 sinusit*:ab,ti OR rhinosinusit*:ab,ti OR nasosinusit*:ab,ti AND [embase]/lim 13953
#15 ’sinusitis’/exp AND [embase]/lim 21736
#14 nasopharyngit*:ab,ti OR rhinopharyngit*:ab,ti AND [embase]/lim 774
#13 pharyngit*:ab,ti OR laryngit*:ab,ti OR tonsillit*:ab,ti OR ’sore throat’:ab,ti OR ’sore throats’:ab,ti AND [embase]/lim 10891
#12 ’sore throat’/de AND [embase]/lim 7948
#11 ’tonsillitis’/exp AND [embase]/lim 7170
#10 ’laryngitis’/de AND [embase]/lim 2091
#9 ’pharyngitis’/exp AND [embase]/lim 15830
#8 bronchit*:ab,ti AND [embase]/lim 15281
#7 ’bronchitis’/exp AND [embase]/lim 33544
#6 pneumon*:ab,ti OR bronchopneumon*:ab,ti OR pleuropneumon*:ab,ti AND [embase]/lim 124552
#5 ’pneumonia’/exp AND [embase]/lim 141952
#4 ’respiratory tract inflammation’/de OR ’inflammation of the lungs, bronchi and pleura’/de AND [embase]/lim 5088
#3 ari:ab,ti OR urti:ab,ti OR lrti:ab,ti AND [embase]/lim 2690
#2 (respiratory NEAR/2 (infect* OR illness OR symptom* OR acute OR virus*)):ab,ti AND [embase]/lim 70124
#1 ’respiratory tract infection’/de OR ’upper respiratory tract infection’/de OR ’viral upper respiratory tract infection’/de OR ’lower
respiratory tract infection’/de AND [embase]/lim 49071
Appendix 3. CINAHL (EBSCO) search strategy
S38 S28 AND S37 398
S37 S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 181,452
S36 (MH “Quantitative Studies”) 8,454
S35 TI placebo* OR AB placebo* 19,960
S34 (MH “Placebos”) 6,623
S33 TI random* OR AB random* 99,149
S32 TI ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*)) OR AB ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*))
14,511
S31 TI clinic* W1 trial* OR AB clinic* W1 trial* 27,568
S30 PT clinical trial 49,810
S29 (MH “Clinical Trials+”) 112,137
S28 S14 AND S27 1,874
S27 S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 169,592
S26 TI (run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong
or qi gong) OR AB (run* or walk* or jog* or sprint* or treadmill* or row* or
swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi gong) 60,655
S25 TI activ* N5 life* OR AB activ* N5 life* 4,190
S24 TI (physical* N5 (fit* or activ* or movement* or train* or condition* or program*)) OR AB (physical* N5 (fit* or activ* or
movement* or train* or condition* or program*)) 24,749
S23 TI ( (weight* or strength* or enduranc* or circuit*) N5 (program* or train* or session*)) ORAB ((weight* or strength* or enduranc*
or circuit*) N5 (program* or train* or session*)) 7,466
S22 TI (exercis* or sport* or fitness* or gym* or aerobic*) OR AB (exercis* or sport* or fitness* or gym* or aerobic*) 64,226
60Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S21 (MH “Dancing+”) 1,535
S20 (MH “Sports+”) 33,190
S19 (MH “Exertion”) OR (MH “Exercise Intensity”) 8,146
S18 (MH “Physical Endurance+”) 5,631
S17 (MH “Physical Fitness+”) 7,255
S16 (MH “Therapeutic Exercise+”) 25,339
S15 (MH “Exercise+”) 47,369
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 42,221
S13 TI (ari or urti or lrti) OR AB (ari or urti or lrti) 333
S12 TI (bronchit* or pneumon* or bronchopneumon* or pleuropneumon*) OR AB (bronchit* or pneumon* or bronchopneumon*
or pleuropneumon*) 10,910
S11 TI (sinusit* or rhinosinusit* or nasosinusit*) OR AB (sinusit* or rhinosinusit* or nasosinusit*) 1,859
S10 TI cough* OR AB cough* 4,012
S9 (MH “Cough”) 2,172
S8 TI (nasopharyngit* or rhinopharyngit*) OR AB (nasopharyngit* or rhinopharyngit*) 70
S7 TI (throat* N3 (infect* or inflam*)) OR AB (throat* N3 (infect* or inflam*)) 85
S6 TI (pharyngit* or laryngit* or tonsillit* or sore throat*) OR AB (pharyngit* or laryngit* or tonsillit* or sore thoat*) 728
S5 TI (influenza* or flu or ili) OR AB (influenza* or flu or ili) 10,739
S4 TI ((acute or viral or virus* or bacter*) N2 rhinit*) OR AB ((acute or viral or virus* or bacter*) N2 rhinit*) 30
S3 TI (common cold* or colds or coryza) OR AB (common cold* or colds or coryza) 888
S2 TI (respiratory N2 (infect* or illness or symptom* or acute or virus*)) OR AB (respiratory N2 (infect* or illness or symptom* or
acute or virus*)) 8,217
S1 (MH “Respiratory Tract Infections”) OR (MH “Bronchitis”) OR (MH “Bronchitis, Acute”) OR (MH “Common Cold”) OR (MH
“Influenza”) OR (MH “Influenza, Human”) OR (MH “Influenza, Seasonal”) OR (MH “Laryngitis”) OR (MH “Pharyngitis”) OR
(MH “Pneumonia+”) OR (MH “Sinusitis+”) OR (MH “Tonsillitis”) 23,907
Appendix 4. LILACS (Bireme) search strategy
INGLS
MH:“Respiratory Tract Infections” OR “Upper Respiratory Tract Infections” OR MH:C01.539.739$ OR MH:C08.730$ OR
MH:Bronchitis OR MH:C08.127.446$ OR MH:C08.381.495.146 OR MH:C08.730.099 OR MH:“Common Cold” OR MH:
C02.782.687.207$ OR MH:C08.730.162$ OR “Cold, Common” OR “Coryza, Acute” OR MH:“Influenza, Human” OR MH:
C02.782.620.365$ OR MH:C08.730.310$ OR Grippe OR “Human Flu” OR “Human Influenza” OR “Influenza in Hu-
mans” OR MH:Laryngitis OR MH:C08.360.535 OR MH:C08.730.368 OR MH:C09.400.535 OR MH:Pharyngitis OR MH:
C07.550.781$ OR MH:C08.730.561$ OR MH:C09.775.649$ OR “Sore Throat” OR MH:C08.381.677$ OR MH:08.730.610$
OR “Experimental Lung Inflammation” OR “Lobar Pneumonia” OR “Lung Inflammation” OR “Pulmonary Inflammation”
OR MH:Sinusitis OR MH:C08.460.692.752$ OR MH:C08.730.749$ OR MH:C09.603.692.752$ OR MH:Nasopharyngitis
OR MH:C07.550.350.700$ OR MH:C07.550.781.500$ OR MH:C08.730.561.500$ OR MH:C09.775.350.700$ OR MH:
C09.775.649.500$ ORMH:Cough ORMH:Tos ORMH:Tosse ORMH:C08.618.248$ MH:C23.888.852.293$ ORMH:Bronchi-
tis OR MH:Bronquitis OR MH:Bronquite OR MH:C08.127.446$ OR MH:C08.381.495.146$ OR MH:C08.730.099$ OR MH:
Bronconeumonía ORMH:C08.127.509$ ORMH:C08.381.677.127$ ORMH:C08.730.610.127$ ORMH:Pleuropneumonia OR
MH:C08.381.677.473$ OR MH:C08.528.735.473$ OR MH:C08.730.582.473$ OR MH:C08.730.610.473$ AND MH:Exercise
OR “Aerobic Exercise” OR “Exercise, Aerobic” OR “Exercise, Isometric” OR “Exercise, Physical” OR “Isometric Exercise” OR MH:
G11.427.590.530.698.277$ OR MH:I03.350$ OR MH:“Exercise Movement Techniques” OR MH:“Exercise Therapy” OR OR
MH:E02.779.483$ ORMH:E02.831.387$ ORMH:“Physical Fitness” OR “Physical Conditioning, Human” ORMH:I03.621$ OR
MH:N01.400.545$ OR MH:“Physical Endurance” OR MH:G11.427.680$ OR MH:I03.450.642.845.054.600$ OR MH:“Exer-
cise Tolerance” OR MH:G11.427.680.270$ OR MH: “Physical Exertion” OR “Physical Effort” OR MH:G11.427.590.780$ OR
MH:Sports OR Athletics OR MH:I03.450.642.845$ OR MH:Dancing OR MH:I03.450.642.287$ OR MH:Gymnastics OR Cal-
isthenics OR MH:I02.233.543.454$ OR MH:I03.450.642.845.417$ OR MH:“Weight Lifting” OR MH:I03.450.642.845.950$
OR MH:“Muscle Strength” OR MH:E01.370.600.425$ OR MH:G11.427.560$ OR MH: “Physical Education and Training” OR
MH:I02.233.543$ OR MH:Running OR MH:G11.427.590.530.568.610$ OR MH:G11.427.590.530.698.277.750$ OR MH:
I03.450.642.845.610$ OR MH:Jogging OR MH:G11.427.590.530.568.610.320$ OR MH:G11.427.590.530.698.277.750.320$
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OR MH:I03.450.642.845.610.320$ OR MH: “Exercise Test” OR Bicycle OR “Ergometry Test” OR “Arm Ergometry Test” OR
“Step Test” OR “Stress Test” OR “Treadmill Test” OR MH:E01.370.370.380.250$ OR MH:E01.370.386.700.250$ OR MH:
E05.333.250$ OR “Prueba Ergométrica de Bicicleta” OR “Test Ergométrico de Bicicleta” OR MH:Swimming OR Natación
OR Natação OR MH:G11.427.590.530.568.800$ OR MH:G11.427.590.530.698.277.875$ OR MH:I03.450.642.845.869$ OR
MH:Bicycling OR MH:I03.450.642.845.140$ OR MH:Yoga OR MH:E02.190.525.937$ OR MH:E02.190.901.984$ OR MH:
E02.779.474.937$ ORMH:K01.844.799.867$ ORMH:“Tai Ji” ORMH:E02.190.525.890$ ORMH:E02.779.474.913$ ORMH:
I03.450.642.845.560.500$ OR MH:“Breathing Exercises” OR “Ch’i Kung” OR “Qi Gong” OR Qigong OR “Respiratory Muscle
Training” OR MH:E02.190.525.186$ OR MH:E02.779.474.124$ OR “Ch’i Kung” OR “Qi Gong” OR Qigong
PORTUGUES
MH:“Infecções Respiratórias” OR “Infecções das Vias Respiratórias” OR “Infecções do Trato Respiratório Superior” OR “Infecções do
Aparelho Respiratório” OR “Infecções das Vias Respiratórias Superiores” OR “Infecções das Vias Aéreas Superiores” OR “Infecções do
Sistema Respiratório” OR “Infecções do Sistema Respiratório Superior” OR “Infecções do Trato Respiratório” ORMH:Bronquitis OR
MH: “Resfriado Comum” OR “Coriza Aguda” OR Catarro OR Resfriado OR Constipação OR MH: “Gripe Humana” OR MH:“In-
fluenza Humana” ORGripe OR “Gripe Humana” OR “Influenza emHumanos” ORMH:Laringite ORMH:Faringite OR Inflamação
OR “Experimental dos Pulmões” OR “Inflamação do Pulmão” OR “Pneumonia Lobar” OR Pneumonite OR “Inflamação Pulmonar”
OR Pulmonia ORMH:Sinusite ORMH:Nasofaringite ORMH:Bronchopneumonia ORMH:Pleuroneumonía ANDMH:Exercício
OR “Exercício Aeróbico” OR “Exercício Isométrico” OR “Exercício Físico” ORMH:“Terapia por Exercício” ORMH:“Aptidão Física”
OR “Estado Físico Humano” OR “Condicionamento Físico Humano” ORMH:“Resistência Física” ORMH:“Tolerância ao Exercício”
ORMH:“Esforço Físico” ORMH:Esportes ORAtletismoORDesportes ORMH:Dança ORMH:Ginástica ORMH:“Levantamento
de Peso” ORMH:“Força Muscular” OR “Educação Física e Treinamento” OR “Educação Física” OR “Educação e Treinamento Físico”
OR MH:“Corrida Moderada” OR MH:Corrida OR MH:Trote OR MH:“Teste de Esforço” OR “Teste Ergométrico de Bicicleta” OR
“Teste Ergométrico com os Braços” OR “Teste de Degrau” OR “Teste de Estresse” OR “Teste de Stress” OR “Teste de Esteira Rolante”
OR “Teste Ergométrico de Esteira” ORMH:Ciclismo ORMH:Yoga OR “T’ai Chi” OR “Tai Chi” OR “Tai Ji Quan” OR “Tai-ji” OR
Taiji OR Taijiquan ORMH:“Tai Ji” ORMH:“Ejercicios Respiratorios” OR “Qi Gong” OR Qigong OR “Exercícios para os Músculos
Respiratórios” OR “Exercício Respiratório”
ESPANHOL
MH:“Infecciones del Sistema Respiratorio” OR “Infecciones de las Vías Respiratorias” OR “Infecciones del Tracto Respiratorio Su-
perior” OR “Infecciones del Aparato Respiratorio” OR “Infecciones de las Vías Respiratorias Superiores” OR “Infecciones del Tracto
Respiratorio” OR “Infecciones Respiratorias” OR MH:“Resfriado Común” OR “Coriza Aguda” OR Catarro OR Gripe “Influenza
Humana” OR “Influenza en Humanos” OR MH:Laringitis OR MH:Faringitis OR “Dolor de Garganta” OR “Dor de Garganta” OR
MH:Pneumonia ORMH:Neumonía ORMH:Pneumonia OR “Pneumonia, Lobar” OR Pneumonitis OR “Inflamación Experimental
del Pulmón” OR “Inflamación del Pulmón” OR “Neumonía Lobar” OR Neumonitis OR “Inflamación Pulmonar” OR Pneumonía
OR Pulmonía ORMH:Sinusitis ORMH:Nasofaringitis ORMH:Broncopneumonia ORMH:Pleuropneumonia ANDMH:Ejercicio
OR “Ejercicio Aeróbico” OR “Ejercicio Isométrico” OR “Ejercicio Físico” ORMH:“Técnicas de Ejercicio conMovimientos” ORMH:
“Técnicas de Exercício e de Movimento” OR MH:E02.779.474$ OR “Técnicas de Ejercicios con Movimiento” OR “Técnicas por
Movimiento de Ejercicio” OR “Técnicas de Movimentos do Exercício” ORMH:“Terapia por Ejercicio” ORMH: “Acondicionamiento
Físico” ORMH:“Resistencia Física” ORMH:“Tolerancia al Ejercicio” ORMH:“Esfuerzo Físico” ORMH:Deportes ORAtletismoOR
Desportos ORMH:Baile ORMH:Gimnasia OR Calistenia OR MH:“Levantamiento de Peso” ORMH:“Fuerza Muscular” ORMH:
“Educación y Entrenamiento Físico” OR “Educación Física” OR MH:Carrera OR MH:“Prueba de Esfuerzo” OR “Test de Esfuerzo”
OR “Prueba Ergométrica del Brazo” OR “Test Ergométrico del Brazo” OR “Prueba del Escalón” OR “Test del Escalón” OR “Prueba
de Estrés” OR “Test de Estrés” OR “Prueba de Esfuerzo en Cinta sin Fin” ORMH:Ciclismo ORMH:Ioga ORMH:“Tai Ji” OR “T’ai
Chi” OR “Tai Chi” OR “Tai Ji Quan” OR Tai-I OR Taiji OR Taijiquan OR MH:“Exercícios Respiratórios” OR “Entrenamiento del
Musculo Respiratorio” OR “Ch’i Kung”
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Appendix 5. SPORTDiscus (EBSCO) search strategy
S40 S33 AND S39 101
S39 S34 OR S35 OR S36 OR S37 OR S38 OR S39 35,613
S38 TI ( crossover* or cross over* ) OR AB ( crossover* or cross over* ) 2,991
S37 TI ( (singl* or doubl*) W1 (blind* or mask*) ) OR AB ( (singl* or doubl*) W1 (blind* or mask*) ) 4,406
S36 TI trial 5,644
S35 TI clinic* W1 trial* OR AB clinic* W1 trial* 4,508
S34 TI placebo* OR AB placebo* 6,609
S33 TI random* OR AB random* 26,226
S32 S19 AND S31 3,150
S31 S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 713,457
S30 TI ( run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong
or qi gong ) OR AB ( run* or walk* or jog* or sprint* or treadmill* or row* or
swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi gong ) 216,308
S39 TI activ* N2 life* OR AB activ* N2 life* 2,393
S28 TI ( physical* N5 (fit* or activ* or movement* or train* or condition* or program*) ) OR AB ( physical* N5 (fit* or activ* or
movement* or train* or condition* or program*) ) 49,909
S27 TI ( (weight* or strength* or enduranc* or circuit*) N5 (program* or train* or session*) ) OR AB ( (weight* or strength* or
enduranc* or circuit*) N5 (program* or train* or session*) ) 22,558
S26 TI ( exercis* or sport* or fitness* or gym* or aerobic* ) OR AB ( exercis* or sport* or fitness* or gym* or aerobic* ) 370,918
S25 DE “DANCE” OR DE “AERIAL dance” OR DE “AEROBIC dancing” OR DE “AFRICAN American dance” OR DE “BAL-
LET” OR DE “BALLROOM dancing” OR DE “BELLY dance” OR DE “BREAK dancing” OR DE “CHA-cha (Dance)” OR DE
“COUNTRY dancing” OR DE “DANCE for people with disabilities” OR DE “FLAMENCO” OR DE “FOLK dancing” OR DE
“FREE skating” OR DE “HIP-hop dance” OR DE “ICE
dancing” ORDE “JAZZ dance”ORDE “LINE dancing” ORDE “LIONdance” ORDE “MODERN dance”ORDE “MOVEMENT
notation” OR DE “ORIGINAL set pattern dance (Skating)” OR DE “POLE dancing” OR DE “ROUND dancing” OR DE “SALSA
(Dance)” OR DE “SHISHIMAI (Dance)” OR DE “SQUARE dancing” OR DE “STEP dancing” OR DE “TANGO (Dance)” OR
DE “TAP dancing” 7,883
S24 DE “PHYSICAL training & conditioning” OR DE “ACROBATICS -- Training” OR DE “ALTITUDE training” OR DE
“ANAEROBIC training” OR DE “ARCHERY -- Training” OR DE “BADMINTON (Game) -- Training” OR DE “BASE training
(Exercise)” OR DE “BASEBALL -- Training” OR DE “BASKETBALL -- Training” OR DE “BICYCLE racing -- Training” OR DE
“BODYBUILDING -- Training” OR DE
“BOWLING -- Training” OR DE “BOXING -- Training” OR DE “BULLFIGHT training & conditioning” OR DE “BUNGEE
jumping training & conditioning” OR DE “CANOES & canoeing -- Training” OR DE “CAVING training & conditioning” OR
DE “COMPOUND exercises” OR DE “CONTRAST training (Physical training & conditioning)” OR DE “COXSWAINING --
Training” OR DE “CRICKET training &
conditioning” OR DE “CROSS-training (Sports)” OR DE “CYCLING -- Training” OR DE “DANCE training & conditioning” OR
DE “DEEP diving training & conditioning” OR DE “DIVING -- Training” OR DE “DOGSLEDDING training & conditioning”
ORDE “ENDURANCE sports -- Training” ORDE “FENCING -- Training” OR DE “FIELD hockey training & conditioning” OR
DE “FOOTBALL -- Training” OR DE “FUNCTIONAL training” OR DE “GLIDING & soaring training & conditioning” OR DE
“GOLF -- Training” ORDE “GYMNASTICS -- Training” ORDE “HANDBALL training & conditioning” ORDE “HIKING train-
ing & conditioning” ORDE “HOCKEY -- Training” ORDE “HUNTING training & conditioning” ORDE “INTERVAL training”
OR DE “ISOLATION exercises” OR DE “KAYAKING -- Training” OR DE “KNIFE fighting -- Training” OR DE “KORFBALL --
Training” OR DE “LACROSSE training & conditioning” OR DE “LONG slow distance training” OR DE “MARTIAL arts -- Train-
ing” OR DE “MOTORSPORTS training & conditioning” OR DE “MOUNTAINEERING -- Training” OR DE “NUNCHAKU --
Training” OR DE “ORIENTEERING -- Training” OR DE “OVERTRAINING” OR DE “PACE training” OR DE “PARACHUT-
ING training & conditioning” OR DE “PARAKITING training & conditioning” OR DE “PERIODIZATION training” OR DE
“PERSONAL training” OR DE “POLO training & conditioning” OR DE “PRACTICE (Sports)” OR DE “PRESEASON (Sports)”
ORDE “RACQUETBALL -- Training” ORDE “RECOVERY training” ORDE “RELAY racing -- Training” ORDE “REPETITION
training” OR DE “RESISTANCE training (Physical
training & conditioning)” OR DE “ROCK climbing -- Training” OR DE “RODEO training & conditioning” OR DE “ROLLER
skating training & conditioning” OR DE “ROWING -- Training” OR DE “RUGBY football -- Training” OR DE “RUNNING -
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- Training” OR DE “SHOT putting -- Training” OR DE “SKATING -- Training” OR DE “SKIS & skiing -- Training” OR DE
“SKYDIVING training & conditioning” OR DE “SOCCER -- Training” OR DE “SOFTBALL -- Training” OR DE “SPEED
endurance training” OR DE “SQUASH (Game) -- Training” OR DE “STRENGTH training” OR DE “SURFING -- Training” OR
DE “SWIMMING --
Training” ORDE “TABLE tennis training & conditioning” ORDE “TEAM handball -- Training” ORDE “TENNIS -- Training” OR
DE “TRACK&field -- Training”ORDE “TRIATHLON --Training”ORDE “TUGofwar (Game) -- Training”ORDE “VAULTING
(Horsemanship) -- Training” OR DE “VOLLEYBALL -- Training” OR DE “WATER polo -- Training” OR DE “WEIGHT training”
ORDE “WHEELCHAIR sports -- Training” ORDE “WINTER sports training & conditioning” ORDE “WRESTLING -- Training”
OR DE “YOGA training & conditioning” 38,599
S23 DE “BALL games” OR DE “ANETSO” OR DE “BALL hockey” OR DE “BALLE au tamis (Game)” OR DE “BASEBALL” OR
DE “BASKETBALL” OR DE “BATTLE ball” OR DE “BICYCLE polo” OR DE “BILLIARDS” OR DE “BOWLING games” OR
DE “BROOMBALL” ORDE “CAMOGIE (Game)” OR DE “CRICKET (Sport)” ORDE “CROQUET” OR DE “DODGEBALL”
ORDE “FIELD hockey” ORDE “FLICKERBALL” ORDE “FOOTBALL” ORDE “GOAL ball” ORDE “GOLF” ORDE “GOLF
croquet” OR DE “HANDBALL” OR DE “HURLING (Game)” OR DE “INDOOR hockey” OR DE “JAPANESE
polo” OR DE “JIAN zi (Game)” OR DE “KANG (Game)” OR DE “KICKBALL” OR DE “LACROSSE” OR DE “LAPTA (Game)”
OR DE “LAWN tempest (Game)” OR DE “MINTON (Game)” OR DE “PARLOR football” OR DE “PARLOR tennis” OR
DE “PICKLE ball” OR DE “PICKLEBALL (Game)” OR DE “PIZE-ball” OR DE “POLO” OR DE “POLOCROSSE” OR DE
“PUSH ball” OR DE “QUIDDITCH (Game)” OR DE “RACQUETBALL” OR DE “RAGA (Game)” OR DE “ROLL ball” OR
DE “ROUNDERS” OR DE “RUGBALL” OR DE “SCHLAGBALL” OR DE “SHINTY (Game)” OR DE “SOCCER” OR DE
“SOFTBALL” OR DE “SPEED-a-way (Game)” OR DE “SPEEDBALL” OR DE “STICKBALL (Game)” OR DE “STOOLBALL”
OR DE “TABLE tennis” OR DE “TCHOUKBALL” OR DE “TENNIS” OR DE “TETHERBALL” OR DE “TRAPBALL” OR DE
“VOLLEYBALL” OR DE “WALLYBALL” OR DE “WATER polo” OR DE “WICKET” OR DE “WIFFLE ball” 108,135
S22 DE “EXERCISE tolerance” 12
S21 DE “PHYSICAL fitness” ORDE “ANAEROBIC exercises” ORDE “ASTROLOGY & physical fitness” ORDE “BODYBUILD-
ING” OR DE “CARDIOVASCULAR fitness” OR DE “CIRCUIT training” OR DE “COMPOUND exercises” OR DE “ISOLA-
TION exercises” ORDE “LIANGONG” ORDE “MUSCLE strength” OR DE “PERIODIZATION training” ORDE “PHYSICAL
fitness -- Genetic aspects” OR DE “PHYSICAL
fitness for children” ORDE “PHYSICAL fitness for girls” ORDE “PHYSICAL fitness for men” ORDE “PHYSICAL fitness for older
people” ORDE “PHYSICAL fitness for people with disabilities” ORDE “PHYSICAL fitness for women” ORDE “PHYSICAL fitness
for youth” OR DE “SPORT for All” 96,632
S20 DE “EXERCISE” OR DE “ABDOMINAL exercises” OR DE “AEROBIC exercises” OR DE “ANAEROBIC exercises” OR DE
“AQUATIC exercises” OR DE “ARM exercises” OR DE “BACK exercises” OR DE “BREATHING exercises” OR DE “BREEMA”
OR DE “BUTTOCKS exercises” OR DE “CALISTHENICS” OR DE “CHAIR exercises” OR DE “CHEST exercises” OR DE
“CIRCUIT training” OR DE “COMPOUND exercises” OR DE “DO-in” OR DE “EXERCISE -- Immunological aspects” OR DE
“EXERCISE adherence” OR DE “EXERCISE for children” OR DE “EXERCISE for girls” OR DE
“EXERCISE for men” OR DE “EXERCISE for middle-aged persons” OR DE “EXERCISE for older people” OR DE “EXERCISE
for people with disabilities” OR DE “EXERCISE for women” OR DE “EXERCISE for youth” OR DE “EXERCISE therapy” OR
DE “EXERCISE video games” OR DE “FACIAL exercises” OR DE “FALUN gong exercises” OR DE “FOOT exercises” OR DE
“GYMNASTICS” OR DE “HAND exercises” OR DE “HATHA yoga” OR DE “HIP exercises” OR DE “ISOKINETIC exercise”
ORDE “ISOLATION exercises” OR DE “ISOMETRIC exercise” ORDE “ISOTONIC exercise” ORDE “KNEE exercises” OR DE
“LEG
exercises”ORDE “LIANGONG”ORDE “METABOLIC equivalent”ORDE “MULANquan” ORDE “MUSCLE strength”ORDE
“PILATES method” ORDE “PLYOMETRICS” ORDE “QI gong” ORDE “REDUCING exercises” ORDE “RUNNING” ORDE
“RUNNING -- Social aspects” OR DE “SCHOOLS -- Exercises & recreations” OR DE “SEXUAL exercises” OR DE “SHOULDER
exercises” OR DE “STRENGTH training” OR DE “STRESS management exercises” OR DE “STRETCHING exercises” OR DE
“TAI chi” OR DE “TREADMILL exercise” OR DE “WHEELCHAIR workouts” OR DE “YOGA” 136,880
S19 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18 9,462
S18 TI ( ari or urti or lrti ) OR AB ( ari or urti or lrti ) 246
S17 TI ( bronchit* or pneumon* or bronchopneumon* or pleuropneumon* ) OR AB ( bronchit* or pneumon* or bronchopneumon*
or pleuropneumon* ) 685
S16 TI ( sinusit* or rhinosinusit* or nasosinusit* ) OR AB ( sinusit* or rhinosinusit* or nasosinusit* ) 129
S15 TI cough* OR AB cough* 839
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S14 TI ( nasopharyngit* or rhinopharyngit* ) OR AB ( nasopharyngit* or rhinopharyngit* ) 10
S13 TI ( throat* N3 (infect* or inflam*) ) OR AB ( throat* N3 (infect* or inflam*) ) 18
S12 TI ( pharyngit* or laryngit* or tonsillit* or sore throat* ) OR AB ( pharyngit* or laryngit* or tonsillit* or sore thoat* ) 48
S11 TI ( influenza* or flu or ili ) OR AB ( influenza* or flu or ili )1,179
S10 TI ( (acute or viral or virus* or bacter*) N2 rhinit* ) OR AB ( (acute or viral or virus* or bacter*) N2 rhinit* ) 3
S9 TI ( common cold* or colds or coryza ) OR AB ( common cold* or colds or coryza ) 5,846
S8 TI ( respiratory N2 (infect* or illness or symptom* or acute or virus*) ) OR AB ( respiratory N2 (infect* or illness or symptom* or
acute or virus*) ) 936
S7 DE “BRONCHITIS” 83
S6 DE “COUGH” 148
S5 DE “PNEUMONIA” 176
S4 DE “SINUSITIS” 114
S3 DE “INFLUENZA” 378
S2 DE “COLD (Disease)” 419
S1 DE “RESPIRATORY infections” 457
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External sources
• None, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
One quasi-RCT (not specifically excluded in our protocol) was found in the search (Weidner 2003). We included it in the review,
although it contributed no data to the meta-analysis.
We changed the title of the review from ’Exercise for acute respiratory infections’ to ’Exercise versus no exercise for the occurrence,
severity and duration of acute respiratory infections’ to more accurately describe the focus of the review.
We included “The proportion of people who experienced at least one ARI over the study period” as a primary outcome even though it was
not nominated in the protocol, because we judged this outcome to be important to the understanding of ARI episodes. Similarly, we
separated the outcome “mean number of ARI symptoms days” (not extractable from most trials) into two new outcomes (“number of
symptom days in the follow-up period” and “number of symptom days per episode”), and included them as primary outcomes.
We had planned to compare exercise with no exercise, usual care, placebo and non-pharmacological treatments, but there were only
data for exercise versus no exercise. We had also planned to calculate a number needed to treat to benefit (NNTB), but there were no
significant dichotomous outcomes (only one continuous outcome was significant).
Had cross-over RCTs been included, we would only have included the phase before crossing over interventions; however, there were
none. Similarly, had cluster-RCTs been included, we would have made statistical adjustments for clustering of participants; however,
there were none.
We planned the following subgroup analyses: patient age; setting of the exercise; whether the exercise was supervised or not; any
associated chronic conditions (asthma, diabetes, hypertension, chronic obstructive pulmonary disease); types of exercise (resistance,
endurance, stretching); frequency of exercise (howmany sessions/week); and intensity of exercise: light (1.6 to 2.9metabolic equivalents
(METs)), moderate (3 to 5.9 METs), vigorous (≥ 6 METs). However, we only had data for length of the intervention, which we had
not planned.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise; Acute Disease; Bicycling; Randomized Controlled Trials as Topic; Respiratory Tract Infections [epidemiology; ∗prevention
& control]; Time Factors; Walking
MeSH check words
Female; Humans; Male
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